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Abstract  
Feline infectious peritonitis (FIP) is a deadly disease of felids with a viral and immune-mediated 
pathogenesis. The nature of the etiological agent – feline coronavirus, FCoV – and the non specific 
clinical presentation make this disease particularly challenging both from a pathogenetic and a 
diagnostic point of view. Many aspects still represent an issue, like not knowing the mutation(s) 
responsible for the development of FIP, the lack of a gold standard for the diagnosis of FIP in vivo 
and the absence of an effective treatment. This thesis was aimed to clarify some of these aspects, 
specifically: a novel test on effusions was developed (namely, Δ total nucleated cell count – ΔTNC 
– i.e. the ratio between the two white blood cell count provided by the Sysmex XT-2000iV 
analyzer) (studies I and II); the frequency of atypical serum protein electrophoresis (SPE) patterns 
in cats with FIP, anecdotally reported during our diagnostic activity (study III) was investigated, a 
comparison of clinico-pathological and molecular tests for the diagnosis of FIP (study IV) was 
performed, a loop isothermal amplification method (LAMP) for the detection of FCoV was 
developed(study V) and an investigation on the prevalence of two mutations of the spike (S) 
protein gene in a wide number of samples from FIP and non-FIP cats was carried out (this latter 
study developed during an externship at the University of Bristol in collaboration with Prof. 
Séverine Tasker and Dr. Emi Barker) (study VI). The results of studies I and II demonstrated that 
the ΔTNC is a reliable method to support the diagnosis of FIP either on fresh or on frozen 
effusions. Study III confirmed that SPE profiles consistent with FIP are less frequent in recent years 
than in the past, possibly due to changes in the pathogenic characteristics of the FCoVs. However, 
study IV demonstrated that: on blood molecular tests may support a clinical diagnosis of FIP but 
none of the test, except the measurement of α1 acid-glycoprotein (AGP) may rule out this disease; 
cytology should be preferred on effusions either to exclude or confirm the disease and, on tissues, 
S  gene sequencing should be preferred when histology is highly consistent with FIP while 3’ UTR 
PCR when FIP is less likely; the LAMP method developed in study V may be used to confirm the 
presence of FCoVs in the samples but is poorly sensitive and cannot exclude the presence of 
FCoVs. Finally, pyrosequencing of FCoV performed in study VI demonstrated the presence of gene 
S mutations also in FCoVs from fecal samples. The analysis of sequences recorded in this latter 
study, however, is still ongoing and future results may provide new insights on the pathogenesis 
and diagnosis of FIP. 
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Abstract (italian version) 
La peritonite infettiva felina (FIP) è una patologia letale dei felidi, a patogenesi virale ed 
immunomediata. La propensione dell’agente eziologico alle mutazioni – coronavirus felino, FCoV – 
e la sintomatologia spesso aspecifica, rendono questa patologia complessa sia dal punto di vista 
diagnostico che patogenetico. Non si è ancora a conoscenza, infatti, della mutazione virale 
responsabile della patologia, non esiste ancora un gold standard per la diagnosi intra vitam e non 
è ancora disponibile una terapia valida. Lo scopo di questa tesi è di tentare di chiarire alcuni di 
questi aspetti. I primi due obiettivi (studio I e II) erano diretti allo sviluppo di un test per la diagnosi 
di FIP in forma effusiva. In particolare, è stata valutata l’accuratezza diagnostica del valore 
ottenuto dal rapporto tra le due conte leucocitarie fornite dal Sysmex XT-2000iV (Δ total nucleated 
cell count – TNCC) su campioni di versamento FIP indotto. Successivamente, è stato valutata la 
possibilità di effettuare lo stesso test su surnatanti di versamenti dopo aggiunta di sangue intero 
felino, in modo da poter ottenere questo valore su campioni congelati o con risultati dubbi ad altri 
esami. Il terzo scopo (studio III) era volto a confermare o smentire la presenza di pattern 
elettroforetici atipici in corso di FIP, come registrato nel nostro laboratorio negli ultimi anni. E’ 
stato quindi svolto uno studio retrospettivo per confrontare pattern elettroforetici in due periodi 
di tempo diversi. Il quarto obiettivo (studio IV) si prefissava di valutare l’accuratezza diagnostica di 
diversi test, sia clinico patologici che molecolari, per trovare il miglior test o la miglior 
combinazione di test per la diagnosi di FIP in vivo. Nello stesso studio è stato anche valutato il 
sequenziamento del gene spike (S), ultimamente proposto come discriminante, quando mutato, 
tra i due patotipi del FCoV. Il quinto scopo (studio V) era di mettere a punto una metodica 
molecolare isotermica (loop isothermal amplification method – LAMP) per il rilevamento del FCoV. 
Questa metodica, essendo veloce ed economica, potrebbe facilitare l’identificazione dei gatti 
eliminatori del FCoV o, per alcuni campioni, la diagnosi di FIP. Durante il mio percorso di dottorato 
ho anche partecipato ad un progetto sotto la supervisione della prof. Séverine Tasker e della 
dott.ssa Emi Barker dell’università di Bristol. Questo progetto (studi VI e VI.1) ha lo scopo di 
scoprire la vera prevalenza, in un ampio numero di tessuti, fluidi e feci ottenute da gatti affetti e 
non affetti da FIP, di due mutazioni del gene spike considerate ultimamente come co-responsabili 
della FIP.   
Gli studi I e II hanno dimostrato che il ΔTNC può essere usato per diagnosticare la FIP con buona 
accuratezza. Lo studio III ha confermato che i pattern elettroforetici tipici di FIP sono meno 
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frequenti negli ultimi anni, possibilmente per modificazioni nella patogenicità dei FCoVs. Dallo 
studio IV si evince che i test molecolari possono confermare la diagnosi di FIP, ma che solo l’AGP 
puo’ escluderla; l’esame citologico dei versamenti dovrebbe essere il test di scelta sui versamenti, 
mentre sui tessuti il sequenziamento del gene S dovrebbe essere usato per confermare la 
diagnosi, mentre la PCR  3’ UTR PCR  quando la FIP è meno probabile. La metodica LAMP 
sviluppata nello studio V si è rivelata molto specifica ma poco sensibile, dimostrandosi un buon 
test per confermare la presenza di FCoV in campioni biologici, ma non per escluderla. Infine, lo 
studio VI  ha messo in evidenza la presenza di coronavirus mutati anche nelle feci di gatti non 
affetti da FIP, mostrando che i successivi progressi in questo studio metteranno in evidenza nuovi 
aspetti della patogenesi della FIP. 
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Introduction 
It was 1963 when the soon to be known feline infectious peritonitis (FIP), a world-wide spread, 
fatal disease of felids, appeared in the scientific milieu as one “important disorder of cats” 
(Holzworth, 1963). Even if the etiological agent of this disease was at that time unknown, some of 
the characteristics described by the Author are still actual, like the frequent occurrence of FIP in 
young cats and the sadly actual lack of any effective treatment (Holzworth, 1963; Pedersen, 2009).  
In the following years, a viral etiology was first proposed by Wolfe and Griesemer (1966) and later 
experimentally confirmed and ascribed to the feline coronavirus (Zook et al., 1968; Ward, 1970; 
Horzinek et al., 1977; Pedersen et al., 1978). Feline Infectious Peritonitis (FIP) is believed to be a 
major cause of infectious disease-associated deaths in the feline population (Hartmann, 2005). FIP 
was and still is an extensively studied disease but, despite the enormous progresses made, several 
aspects about both the pathogenesis and the diagnosis of FIP are still yet to be known, making FIP 
one of the most feared as well as challenging disease of felids (Kipar and Meli, 2014; Pedersen, 
2014a). 
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Feline coronavirus 
Coronaviruses are well known for their impact on both human and animal health, being the 
causative agents of diseases like severe acute respiratory syndrome (SARS), middle eastern 
respiratory syndrome (MERS), infectious bronchitis in chickens and transmissible gastroenteritis in 
pigs (Weiss and Navas-Martin, 2005; Hilgenfeld and Peiris, 2013). Feline coronaviruses (family 
Coronaviridae, order Nidovirales) are enveloped, single-stranded positive sense RNA viruses 
belonging to the species Alphacoronavirus 1, genus Alphacoronavirus of the sub family 
Coronavirinae (Gonzales et al., 2003). Feline coronavirus genome is about 30 kb long and 
organized in 11 open reading frames (ORFs) (Figure 1). The majority of the genome is represented 
by the two 5’ proximal, overlapping ORF 1a and ORF 1b, which are translated as polyproteins 
pp1ab and pp1a by frame-shifting and non frame-shifting mechanisms respectively (Sawicki et al., 
2005; Pedersen, 2014a). These polyproteins include 16 non-structural proteins (nsps) which have 
replication associated activities (genome replication, proteolytic processing and multiple 
subgenomic mRNA synthesis) and form a membrane-bound replication-transcription complex 
through interaction with the endoplasmic reticulum and Golgi apparatus of the infected cell 
(Prentice et al., 2004). The remaining 9 ORFs encode for four structural proteins (envelope, E; 
membrane, M; nucleocapsid, N and spike, S) and for 5 group-specific, accessory proteins (3a-c, 
located between the S and the E genes, and 7a-b, located at the 3’ end of the genome) (Haijema et 
al., 2004).  
 
Figure 1. FCoV genome organization. From 1-16 the non structural proteins translated by the ORF1a and 1b 
are represented (Lewis et al., 2015). 
 
These proteins are expressed from a set of 3' coterminal subgenomic (sg) mRNAs generated via 
discontinuous transcription during subgenome-length minus-strand RNA synthesis (Hagemeijer et 
al., 2012). The E, M and S proteins constitute the viral envelope, which surrounds the viral RNA 
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genome in association with the nucleocapsid protein (Li, 2016). The Envelope (E) proteins are 
small (around 9 kDa) hydrophobic, non glycosilated viroporins which mainly distribute between 
the endoplasmic reticulum and the Golgi apparatus membranes of the infected cell, where they 
actively participate in virion assembly, morphogenesis and egress (Dye and Siddell, 2005; 
Venkatagopalan et al., 2015). The membrane (M) proteins, despite their low molecular weight 
(around 30 kDa), are the most abundant protein in the viral envelope, with three transmembrane 
(TM) domains and a conserved overall structure among coronaviruses. Together with the E 
proteins, they play important roles in the virions morphogenesis, assembly and budding (Dye and 
Siddell, 2005; Ujike and Taguchi, 2015). The nucleocapsid (N) protein has a molecular weight of 
around 43 kDa and its primal role is to package the viral RNA in into long, flexible, helical 
complexes called nucleocapsids, which are incorporated during the budding process of the viral 
infection. It is dynamically associated with the replication-transcription complex and it also plays 
an essential role in the viral genome replication and in the sub genomic RNA synthesis (Dye and 
Siddell, 2005; Gorbalenya et al.,2006; Verheije et al., 2010; McBride et al., 2014). The N protein is 
the most immune-dominant FCoV antigen and several studies demonstrated its potential role in 
the protection against FIP, being responsible of a cell-mediated immune response (Hodatsu et al., 
2003; Battilani et al., 2010; Rossi et al., 2011). The spike (S) proteins (160 kDa) are responsible for 
the name coronavirus (corona is the latin word for crown), since they form 20 nm long protrusions 
that extend from the viral envelope (Bosch et al., 2003; Dye and Siddell, 2005; Li, 2016). They are 
class I virus fusion proteins formed by three segments: a large ectodomain composed by a 
receptor-binding subunit (S1) and by a membrane-fusion subunit (S2), a single-pass 
transmembrane anchor, and a short intracellular tail. The S1 subunit is responsible of binding to 
receptors on the host cell surface for the virus entry, while the S2 subunit allows the viral genome 
to enter the host cell, through fusion of the host and viral membranes (Li, 2016). Coronaviruses 
accessory proteins are thought to be not essential for in vitro replication, but to play essential 
roles for virus-host interactions, viral virulence and pathogenesis. To this day, feline coronavirus 
accessory proteins exact roles are still unclear (Dedeurwaerder et al., 2013; Liu et al., 2014). The 
3a and 3b accessory proteins consist of 71 amino acids (aa) and they probably have intracellular 
functions, due to the lack of signal peptides or transmembrane domains. The 3c protein is a class 
III triplemembrane spanning protein of 238-244 aa, resembling the M protein of the FCoVS and 
the 3a protein of the SARS-CoV (Dedeurwaerder et al., 2013). This protein seems to be necessary 
for the survival and replication of the virus in the enteric environment (Chang et al., 2010). The 7a 
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protein is a hydrophobic, well conserved among FCoVs protein of 101 AA. The 7b protein consists 
of 207 aa and has showed several single amino acid polymorphisms among FCoV strains. It is 
secreted from infected cells and it is probably involved in the modulation of the host immune 
response (Herrewegh et al., 1995a; Dedeurwaerder et al., 2013). 7a and 7b proteins appear to be 
essential for an efficient replication in vitro as well as for virulence in vivo (Haijema et al., 2004; 
Dedeurwaerder et al., 2013). It was also recently showed that the 7a protein could protect the 
virus survival acting as a type I interferon (I IFN) antagonist, but it can exert its antagonistic 
functions only through the presence of the 3a-c proteins (Dedeurwaerder et al., 2014).  
After the S protein-mediated recognition and binding of the virus to the host cell, the coronavirus 
envelope must fuse with the target cell membrane in order to release the viral genome in the host 
cell cytoplasm (Cavanagh, 2005). This process seems to be mediated by cleavage of the S1/S1 
subunits that, in feline coronaviruses, is performed by specific monocytes/macrophages proteases 
not yet fully characterized (Licitra et al., 2013). After the entry in the host cell, coronaviruses 
induce the formation of membranous structures called double membrane vesicles (DMVs), 
described only for SARS-CoV and mouse hepatitis virus (MHV) and in a not still completely 
understood manner, on which the replication transcription complex is anchored and the RNA 
synthesis occurs (van Hemert et al., 2008; Perlman and Netland, 2009; Hagemeijer et al., 2012). 
The replication takes place through RNA-dependent RNA polymerase (RdRp). The genomic 
positive-sense RNA is copied into a negative-sense template until it reaches a transcription-
regulation sequence (TRS). At this point, RNA synthesis may either continue or the negative-sense 
sgRNA is completed after the relocation of the RdRp to the 5' end of the genome. The synthetized 
RNA is then incorporated into the virions on membranes located between the endoplasmatic 
reticulum (ER) and the Golgi apparatus (ER-Golgi intermediated compartment: ERGIC) (Hagemeijer 
et al., 2012). After the translocation of the RNA and the N protein to the ERGIC and the Golgi 
region, where the viral glycoproteins are located, the newly formed virion is released from the 
host cell through the budding process (Stertz et al., 2007).  
Among the RNA viruses, coronaviruses possess the largest genome and they lack of a proofreading 
activity, making mutations easy to occur. Even if mechanisms of “alternative” proofreading have 
been experimentally demonstrated (the inactivation of the nsp14, which encodes for an 
exonuclease, of SARS-CoV and MHV leads to a 15- to 20-fold increased mutation rates), mutations 
do happen and induce some of the most important characteristic of RNA viruses: the ability to 
adapt themselves to different environments and to change cell or even host tropism. The result of 
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this process is the formation of quasispecies, which are related but not identical genomes, 
subjected to not stopping processes of genetic variations, competition and selection (Denison et 
al., 2011; Domingo et al., 2012). The concepts of quasispecies formation and genetic 
recombination typical of coronaviruses are important in order to understand feline coronaviruses 
behavior and their subdivision in two serotypes (FCoV I and FCoV II) as well as in two pathotypes 
(feline enteric coronavirus, FECV; feline infectious peritonitis virus, FIPV). The two FCoV serotypes 
can, in fact, be recognized based on their link with canine coronavirus (CCoV). Virus-neutralizing 
antibody reactions and comparison of amino acid sequences of the spike protein demonstrated 
that the FCoV II is the result of a genome recombination between the CCoV and the FCoV, where 
the CCoV spike gene was incorporated into FCoV type I (Herrewegh et al., 1995a; Motokawa et al., 
1996). Type I FCoV grows poorly in vitro, while type II strains grow well and are, for this reason, 
more used for experimental studies. This is in contrast with what happens in the field, since type I 
FCoVs are more globally diffused, while type II FCoVs are less diffused and represent the 10-20% of 
FCoVs isolated in Asia (Rottier, 1999; Sharif, et al., 2010; Pedersen, 2014a). The two strains also 
differ for the receptor used to enter the cells. Feline aminopeptidase N is as a receptor for type II 
FCoV, but not for type I FCoV. Type I FCoV uses a feline dendritic cell-specific intercellular adhesion 
molecule-grabbing nonintegrin (fDC-SIGN) as a co-receptor, together with a mannose-binding 
lectin or another receptor of still unknown origins (Regan et al., 2010; van Hamme et al., 2011). 
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Feline infectious peritonitis  
Role of FCoV mutations 
The two pathotypes of FCoV refer to their capability of causing FIP. This because while it is now 
fully accepted the hypothesis for which FIPV derives from mutations of the FECV within each cat, it 
is still not understood which is the real mutation responsible for this switch. As reported by Gunn-
Moore et al. (1999): “FCoV exists within individual cats as complex viral populations”. When one of 
the quasispecies generated during the replication-transcription process acquires the capability of 
changing cell tropism from enterocytes to monocytes/macrophages, along with an impaired 
immune response of the host, FIP occurs (Pedersen, 2009). FECV, in fact, is primarily confined to 
the intestinal tract, where it causes a mild enteritis (Rottier, 1999). The FECV was believed for 
years to be confined to the host intestinal epithelium, but several studies have demonstrated that 
FECV can spread systematically through monocytes-associated viremia in infected, but healthy, 
cats (Gunn-Moore et al., 1998a). Nevertheless, the FECV was also demonstrated not only to be 
carried, but also to freely replicate in the host monocytes, when this was believed to be only a 
FIPV trait. Moreover, cats shed FCoV in the feces after been inoculated intraperitoneally with the 
FECV, even if to a lesser extent compared with cats inoculated with FIPVs. Thus, the real difference 
between the two pathotypes seems to be the higher and more effective rate of replication inside 
the blood monocytes of the FIPV compared with the FECV (Simons et al., 2005; Can-Sanha et al., 
2007; Pedersen et al., 2012). 
The first gene taken into account for its role in the FECV-to-FIPV switch was the accessory 3c gene. 
The majority of the FIPVs isolated from FIP cats showed deletions in the 3c gene (Vennema et al., 
1998). Structural and accessory genes of FIPV strains obtained from affected tissues were 
sequenced, showing that the highest number of mutations were located in the 3c gene and were 
represented mostly by randomly scattered single nucleotide polymorphisms (SNPs) that led to 
variable truncations of the 3c protein. These mutations were also present in the FECVs obtained 
from the feces of the same cats, but to a lesser extent. Interestingly, the type and number of 
nucleotide deletions were always different between the different strains, confirming that each 
mutation arises independently in each cat (Pedersen et al., 2009). When the 3c genes were 
sequenced from a higher number of FIPVs and FECVs, mutations in the 3c gene were found in the 
majority, but not in all, the FIPVs, while none of the FECVs obtained from feces showed the 
mutations. The authors concluded that an intact 3c gene is essential for the replication in the host 
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intestine, but also that 3c gene mutations are not the only responsible for the FECV-to-FIPV switch 
(Chang et al., 2010). This latter finding was later on confirmed, since FIPVs with mutated 3c genes 
were not shed in the feces after oronasal inoculation, while FIPVs with an intact 3c gene were. 
Again, the 3c gene mutation was confirmed not to be the only cause of FIP, since both mutated 
and non mutated 3c gene FIPVs were capable of inducing FIP after oronasal or intraperitoneal 
inoculation. Additionally, FIPVs with an intact 3c gene contained more amino acidic changes in the 
3c protein than FECVs, making this gene very variable between different strains (Pedersen et al., 
2012). A more recent study investigated the clonal diversity of 3c genes obtained from FIP and non 
FIP cats, with the aim to detect not only the dominant sequences but a higher number of 
sequences that may harbor the mutation. As a result, all the FIPVs showed the truncated 3c gene, 
in contrast with what previously reported and consequently defining the 3c gene as a promising 
marker for the FECV-to-FIPV switch (Hora et al., 2016). The real function of the 3c gene is, 
however, still not clear. Due to its hydropathy profile similar to that of the SARS-CoV 3a protein, it 
was postulated that the 3c protein could have similar functions (pro-apoptotic properties and 
virion release), but this still remains only a hypothesis (Pedersen, 2014a). A recent study showed 
that the 3c protein could have a virulence suppressing effect, aimed to maintain the symbiosis 
between the host and the virus, using a pathway not involved with autophagy. It was also 
hypothesized that a truncated 3c protein could subsequently enhance the viral replication in 
macrophage-like cells (Hsieh et al., 2013).  
The ORF 7a/7b were also early investigated as potential markers of virulence. A first study by 
Herrewegh et al. (1995a) showed that while the 7a protein was well conserved among FCoV 
strains, the 7b protein amino acid sequences were less similar between strains. Moreover, when 
comparing avirulent FIPVs strains with FCoVs 7b sequences after tissue culture passages, 
nucleotide deletions of different lengths were found in the avirulent FIPVs strains. When the same 
comparison was performed on samples collected from naturally infected and FIP affected cats, the 
deletion in the ORF 7b were not present. The authors concluded that while the ORF7b is not 
necessary for in vitro replication, thus easily lost, it somehow gives advantages for in vivo 
replication and that deletions in this protein could diminish the virus virulence (Herrewegh et al., 
1995a). The same findings were confirmed by another study, where viruses with a truncated 7b 
gene have been associated with enteric coronaviruses only (Vennema et al., 1998), but when the 
expression of the 7b protein was investigated as its mutation could really be a distinctive tract 
between FECV and FIPV, the results were quite different. A study aimed to evaluate the antibody 
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response against the 7b protein in FIP affected cats demonstrated that both FIP, non FIP and 
healthy cats had antibodies against this protein (Kennnedy et al., 2008). In a following study, 7b 
proteins with deletions were found both in FCoV from fecal samples of infected, healthy cats and 
in effusions of FIP affected cats. Thus, the presence of deletions in 7b protein is not correlated 
with the viral pathogenicity and cannot be used to distinguish FECVs from FIPVs (Lin et al., 2009). 
The role of the spike gene in the pathogenesis of FIP has began to be thoroughly investigated in 
the last few years, precisely after a paper published in 2012 by Chang et al. In this study, 11 FCoVs 
obtained from tissues of FIP affected cats and 11 FCoVs obtained from feces of healthy cats were 
sequenced and subjected to a screening for nucleotide differences among the two pathotypes. In 
the 10% of the genome positions, the nucleotide identity in at least 1 of the 11 FIPVs did not occur 
in any of the 11 FECVs and almost a half of these differences were due to differences in the spike 
gene. One nucleotide difference was found in 9/11 FIPVs (nucleotide T or C at position 23531) and 
in none of the FECVs (nucleotide A at position 23531). The mutation of this single nucleotide leads 
to the modification of one amino acid (from methionine to leucine at position 1058) in the fusion 
peptide of the spike protein. When analyzed on a larger scale, the same finding was present in the 
96% of FIP cats, while another single nucleotide mutation in close proximity (mutation S1060A) 
allowed to additionally distinguish FIPVs from FECVs. Given the functions of the spike protein in 
coronaviruses (cell targeting and cell entry) the authors concluded that this mutation is probably 
associated with the FIPV pathogenicity, but that is also most likely not the only responsible for the 
FECV-FIPV switch (Chang et al., 2012). A year later, a study from Licitra et al. (2013) showed a set 
of at least one nucleotide mutations in the S1/S2 furin cleavage site of FIPVs, but not in the FECVs. 
In particular, more than 40 % of FIPVs showed mutations (e.g. deletions) in the arginine residue of 
the P1 position of the cleavage site. The next more common mutations of the FIPVs was in the P2 
position. These mutations, however, even if believed to be associated with an enhanced tropism 
for monocytes and macrophages, were found only in two thirds of the genomes analyzed and led 
also to a sometimes higher, sometimes lower cleavage efficiency, leaving doubts about the real 
meaning of these findings (Licitra et al., 2013). The same author extended this work by additionally 
investigating possible mutations at the S2’ cleavage site, which is the second cleavage activation 
site of the S protein, from FECVs obtained from feces of healthy cats and from FIPVs collected by 
FIP clinically and sometimes immunohistochemically diagnosed cats. Again, mutations were 
present in both the cleavage sites obtained from FIPVs, but the patterns were complex and often 
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different between the different cats or even samples from the same cat, both in terms of 
interested position and in terms of amino acid change in the same position (Licitra et al., 2014). 
In a more recent study, the main mutation described by Chang et al. was investigated in an 
extended cohort of fecal and tissue samples from both FIP and non FIP cats. Surprisingly, 9% of the 
tissue from FIP cats did not showed the mutations proposed by Chang et al. (2012) and, at the 
same time, 89% of tissues from non FIP cats showed the mutation M1058L described by Chang as 
typical of FIP. This result can be explained with a possible association of the mutation with a 
systematic spread of the FCoV, rather than to a pathogenic role of the mutated gene (Porter et al., 
2014).  
 
Epidemiology, shedding and transmission 
Even if with wide variability among different countries, feline coronavirus is worldwide spread as 
well as feline infectious peritonitis (Drechseler et al., 2011). The prevalence of FCoV is extremely 
high, especially in multicat environments, where the seroprevalence can reach more than 90%, 
while in single-cat households it is between 10-50% (Horzinek and Osterhaus, 1979; Addie and 
Jarrett, 1992; Addie et al., 2000; Pedersen et al., 2004). Feline coronavirus is fecally-orally 
transmitted, therefore the risk of becoming infected increases in crowded conditions (Cave et al., 
2004). Due to its high prevalence, FIP could be expected to be a very common disease. Conversely, 
its incidence is low, and only 5-12% of FCoV infected cats develop FIP (Drechsler et al., 2011). The 
viral fecal shedding usually begins a week after experimental infection with FECVs or at 9-10 weeks 
of age for kittens born from infected queens, and continues for up to 10 months, after which the 
pattern of shedding can follow three ways. About 5% of the cats develop a strong immune 
response and stop the shedding after an average time of 12 months; about 70-80% of the cats 
discontinuously shed the virus (intermittent shedders) and 10% of the cats persistently shed the 
virus for more than 24 months and possibly lifelong (Foley et al., 1997; Addie and Jarrett, 2001; 
Pedersen et al., 2008). The persistent shedders seem to be persistently infected with the same 
strain of the virus, while cats that recover from the infection are susceptible to be re-infected, 
either with the same or different viral strains (Addie et al., 2003). Persistent, healthy shedders, 
with the colon as the main site of viral persistence, play a key role in the epidemiology of FIP (Meli 
et al., 2004; Kipar et al., 2010).  
Viral shedding is also correlated with the antibody titer, since cats shedding the virus usually have 
higher titers in comparison with non shedders (Pedersen et al., 2008). There are several risk 
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factors for the development of FIP. FIP usually occurs in young cats, typically after 5-6 weeks of 
age, when the maternal antibodies decrease. Stressful events (e.g. surgery, moving, co-infections) 
can be risk factors, as well as the proportion of shedders in the cattery, since the entrance of FCoV 
infected cats in multi-cat environments can increase the viral shedding from 10- to 1 million-fold in 
one week only. It has been in fact postulated that higher levels of viral replication could lead to the 
occurrence virulent mutants among the quasispecies generated by infected animals due to the 
high rate of viral mutations (Foley et al., 1997; Gunn-Moore et al., 1999; Hartmann, 2005). 
Moreover, FIP seems to occur more often in male, intact cats and during fall-winter, probably due 
to the fact that cats tend to share the same environments (Rohrbach et al., 2001; Pedersen et al., 
2004). Certain breeds are reported to be more likely to develop FIP: Birman, Ragdoll, Rex, 
Abyssinian and Himalayan breeds (Pesteanu-Somogyi et al., 2006).  
FIP usually arises as an enzootic disease, with rare and unpredictable losses, usually of 1-5% 
distributed in a 5 year or longer period. Occasionally, however, it can arise as an epizootic disease, 
with typical FIP outbreaks characterized by the occurrence of FIP in about 10% of the cats, 
depending on the general prevalence of FIP in the given environment. The causes of FIP outbreaks 
are multifactorial and due to overcrowding, increased intestinal replication rate and a general 
increased stress level (Pedersen, 2009; Drechsler et al., 2011). Outbreaks events, even if rare, 
could suggest the presence of virulent strains capable of inducing FIP in a given population (Brown 
et al., 2009). This hypothesis was recently proved wrong, when it was demonstrated that the viral 
strains isolated during an FIP outbreak from FIP and FCoV infected cats were very closely related 
and that no evidence of circulating virulent-avirulent strains was found (Barker et al., 2013). 
 
Pathogenesis of FIP 
There are several unclear aspects about the pathogenesis of FIP. As stated above, it is still 
unknown, for example, the mutation responsible for the FECV-to-FIPV switch. Several studies 
published in the last years allow to recognize some key factors in the pathogenesis of FIP, which 
are the change of tropism of the FCoV from enterocytes to monocytes, the acquired capability of 
actively replicating in these cells, and an imbalance between the host cell-mediated and humoral 
immune response (Kipar and Meli, 2014). After oral experimental infection, FCoV targets the 
intestinal columnar epithelial cells. It is then probably taken up by enteric macrophages to the 
lymph node, from where they can be systemically spread and detected in the blood as well as in 
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the tissues resident macrophages (Kipar et al., 2010). The site of FECV-to-FIPV switch is still 
unknown, but the blood monocytes could intermediate this process (Pedersen, 2014a).  
The manifestation of FIP and how it clinically manifests depend on the host immune response. 
FCoV infected cats develop antibodies against the virus, no matter on the following course of the 
infection but, while some animals clear the infection, many remain infected or develop FIP (Vogel 
et al., 2010). The humoral response has, in fact, a supportive role in the development of FIP, while 
a strong cellular immune response has a protective role against the disease (Pedersen and Black, 
1983). Cats with FIP show a decreased Th1 protective response, with a general decrease in the 
lymphocyte number and a specific decrease in the T cell subsets, which occurs very early after 
experimental infection and correlates with viral replication in blood (Gunn-Moore et al., 1998b; 
Kipar et al., 1998; Kipar et al., 2001; Paltrinieri et al., 2003; De Groot-Mijnes et al., 2005).  
The cytokine patterns found in FIP cats support these findings, since an inhibition of the cellular 
immune response due to the lack of the interleukin 12 (IL-12) leads to activation of monocytes and 
macrophages and, eventually, to FIP. On the other hand, FCoV-infected, healthy cats can avoid this 
hyperactivation thanks to the up-regulation of the interleukin 10 (IL-10), a cytokine with anti-
inflammatory activities (Kipar et al., 2006a). Moreover, an upregulation of the tumor necrosis 
factor α (TNF- α) and a decrease in the interferon γ (IFN-γ) are generally found in FIP cats, since 
these two cytokines have an inducive and a protective role in the development of FIP, respectively 
(Kiss et al., 2004; Gelain et al.,2006). TNF-α, in fact, could be responsible for both induction of 
apoptosis in T cells, primarily CD8+ T cells, and for the increased expression of feline 
aminopeptidase N, the receptor used by FIPV II for entering the monocytes (Takano et al., 2007a;  
Takano et al., 2007b). In other studies, similar concentrations of IFN-γ were found in the blood of 
FIP and healthy cats, while high level were found both in FIP effusions and lesions. It is therefore 
more likely that this cytokine is released at the lesion level, where it increases macrophages 
hyperactivation and viral uptake (Berg et al., 2005; Giordano and Paltrinieri, 2009). 
Humoral response has been shown to support FIP development through a antibody-mediated 
enhancement (ADE) process. Antibodies against the spike protein facilitate the uptake of the virus 
from the monocytes through Fc receptors. This finding, however, seems to be more evident in 
vitro than in vivo (Olsen et al., 1992; Addie et al., 1995). If ADE plays only a secondary role in the 
infection in vivo, the question why the infected monocytes are not able to clear the infection 
remains open. A recent study investigated the role of the innate immune response, showing that 
FIP affected cats have a drastic decrease in the natural killers (NK) and T regulatory (Tregs) cells in 
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blood, lymph nodes and spleen. NK have anti-viral activities, while Tregs modulate the immune 
response and their decrease could explain the incapability of inducing both a decrease of the viral 
load and the monocytes activation. Curiously, intralesional NKs do not change in number and 
show activation, but this finding does not translate in an increased cytolytic activities, possibly due 
to changes in NK cell biology or activation (Vermeulen et al., 2013). It is clear that the picture of 
FIP pathogenesis is still complex.  
What is known is that the infected monocytes/macrophages activation start a sequence of events 
that, depending on the host immune response, will determine the manifestation of the disease. 
 
Pathological findings 
A strong humoral immune response causes the effusive (or ‘wet’) form of FIP. The pathological 
features of effusive FIP were firstly linked to a type III hypersensitivity. The immune-complexes 
resulting from the linking of antibodies with viral particles and viral laden macrophages cause an 
Arthus-like reaction, associated with the deposition of the complexes around small venules, which 
trigger the release of macrophage produced factors that cause tissue damages and the 
development of an inflammatory process characterized by pyogranulomas, vasculitis, necrosis and 
effusions (Weiss and Scott, 1981; Pedersen, 2009). The activation of macrophages, mediated by 
the production of IFN-γ, results in the increased viral replication which, in turn, further fosters the 
inflammatory process (Berg et al., 2005). It was also recently demonstrated that FIPV-infected 
macrophages induce the endothelial cells to express P-selectin, E-selectin, intercellular adhesion 
molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) which, in turn, support the 
adhesion of leukocytes to endothelial cells and their transmigration. This could explain not only 
the systemic spread of FIP lesions, but could also give further insights about the development of 
typical FIP lesions (Acar et al., 2016). Some aspects of FIP lesions do not correlate with type III 
hypersensitivity, like the involvement of arteries in the inflammatory process. FIP vasculitis, in fact, 
is usually confined to small and medium size veins (Kipar et al., 2005).  
Pyogranulomas are considered the histological hallmark of effusive FIP. Their localization follows 
the course of the cranial mesenteric artery and the lesions are therefore more concentrated on 
the omentum and on the abdominal serosal surfaces, but pleura and pericardium can also be 
involved. Histologically, pyogranulomas are composed by a high number of macrophages 
containing a large amount of internalized viruses, few surrounding plasma cells, lymphocytes and 
a variable number of neutrophils depending on the amount of necrosis (Kipar et al., 1998; Berg et 
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al., 2005; Pedersen, 2009). Effusive FIP is also associated with the presence of large volumes of a 
yellow, thick, proteinaceous effusion rich in plasma proteins and hemoglobin breakdown products, 
often containing fibrin clumps (Drechsler et al., 2011). Effusion is typically abdominal, but the 
thorax and, less frequently the pericardium, can also be involved (Hartmann, 2005). A critical role 
in the effusive form is played by the vascular endothelial growth factor (VEGF) produced by FIPV 
infected macrophages, which seems to induce hyperpermeability of feline vascular endothelial 
cells (Takano et al., 2011).  
The different pathogenesis of non effusive FIP reflects also the different pathological features, 
characterized by granulomas. Type IV sensitivity may play a role in the development of non 
effusive, granulomatous FIP lesions, due to the presence, in the focal lesions, of CD4+ 
lymphocytes, neutrophils and macrophages (Paltrinieri et al., 1998). Compared with 
pyogranulomas, macrophages in granulomas contain less or none viral antigen (Kipar et al., 1998; 
Pedersen, 2009). Abdominal and thoracic lesions of non effusive FIP probably originates from the 
serosa/pleura and then infiltrate the underlying parenchyma (Pedersen, 2009). Eyes and central 
nervous system (CNS), with lesions on the uvea and meninges/ependyma respectively, are usually 
more interested than in the effusive form of FIP (Drechsler et al., 2011).  
The effusive and non effusive form are not always two pathological distinct forms, since at gross 
examination the effusions can be present along with granulomatous lesions typical of non effusive 
FIP. Also, vasculitis, which should be more typical of effusive FIP, can be observed in kidneys with 
granulomatous lesions caused by non effusive FIP (Berg et al, 2005; Kipar and Meli, 2014).  
Uncommon manifestations of FIP are also described. Intestinal solitary lesions due to FIP, 
manifesting as unusually enlarged lymph-nodes or as intramural, solitary masses in the colon or in 
the ileocecocolic junction, resembling a neoplasm, have been described (Harvey et al., 1996; Kipar 
et al., 1999). An uncommon “encapsulation” of the pleural effusion, resembling a mediastinal cyst, 
was also described (Vigani, et al., 2009). Peritonitis can involve the tunica vaginalis, causing scrotal 
enlargement, and testicles or penis can be involved in the inflammatory process as well (Pedersen, 
1995; Sigurðardóttir et al., 2001; Rota et al., 2008). Skin lesions caused by FIP have been also 
described (Trotman et al., 2007; Declercq et al., 2008; Bauer et al., 2013).  
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Clinical and diagnostic features 
The diagnosis of FIP is a very important step, both for the unavoidability of the poor prognosis and 
for the psychological and economic impact on owners and cat breeders. Nevertheless, this step is 
still considered challenging and even frustrating for the veterinarian, since at this day there is still 
not a gold standard for the diagnosis in vivo (Pedersen, 2014b). One of the main reason for this, is 
the impossibility to distinguish between the FECV and the FIPV either using serology or using 
polymerase chain reaction (PCR)/sequencing-based approaches and the fact that the majority of 
cats (i.e. also those with symptoms consistent with FIP but due to diseases other than FIP) is 
infected with the FCoV makes the picture even more complex (Addie et al., 2009; Pedersen, 
2014b). Another important reason is the non specificity of the clinical signs, especially in the non 
effusive form, in which the symptoms are correlated with the organs involved by the granulomas. 
For these reasons, the diagnosis of FIP must be based on a detailed signalment and anamnesis and 
on a panel of laboratory tests that sometimes can be not conclusive. 
FIP is more frequent in young cats, usually between 4 and 36 months and typically under 2 years 
of age (Norris et al., 2005; Pedersen, 2014b; Riemer et al., 2015). Typical and non specific signs are 
persistent, antibiotic unresponsive fever, lethargy, general discomfort, jaundice, inappetence and 
weight loss. Sometimes, however, signs can be absent and FIP lesions can become apparent only 
during routine surgery (Addie et al., 2009; Pedersen, 2009). In the effusive form, ascites with 
abdominal distension is the most common finding. Pleural effusion, alone or in concomitance with 
ascites, can cause dyspnea (Addie et al., 2009). Signs of non effusive FIP depend on which organ is 
affected by the lesions. Abdominal palpation may reveal just a thickened intestinal area or lymph 
nodes enlargement, while sometimes it can reveal the presence of granulomatous lesions as 
irregularities on the kidneys surface (Drechsler et al., 2011). Ocular involvement is frequent in non 
effusive FIP, and it manifests with retinal vasculitis, with perivascular cuffing of inflammatory cells 
and sometimes retinal detachment, and uveitis, with fibrin and keratic precipitates in the anterior 
chamber (Maggs, 2009; Stiles, 2014). Neurological signs are also more frequent in non effusive FIP, 
reflecting the type and scale of involvement of the brain, meninges and spinal cord. Consequently, 
the range of clinical signs is wide and comprises behavioural changes, hyperesthesia, cranial 
nerves abnormalities, caudal paresis, ataxia and seizures (Foley et al., 1998; Gunn-Moore and 
Reed, 2011). After the emission of a clinical suspicion of FIP, the clinician must deal with a range of 
laboratory tests, more vast in effusive FIP, that might increase the odds of making the right 
diagnosis. 
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Hematology and serum biochemistry 
Non regenerative anemia, ascribable to a chronic inflammatory illness, is usually found in FIP. 
Other complete blood count (CBC) alterations are leukocytosis with absolute neutrophilia and 
lymphopenia. These two findings, however, can also be found in the stress leukogram that can be 
due to many other diseases (Paltrinieri et al., 2001; Addie et al., 2009; Pedersen, 2009). In a recent 
study performed on a large cohort of FIP cats, lymphopenia was observed in only half of the cats 
and significantly more often in cats with effusive FIP (Riemer et al., 2015).  
In serum, an increase in hepatic enzymes, urea and creatinine may reflect the involvement of liver 
and kidneys, if present, but these changes are usually not helpful in formulating a diagnosis (Addie 
et al., 2009). Hyperbilirubinemia and sometimes hyperbiliverdinemia are often present, not in 
correlation with jaundice or liver involvement. These findings are more common in the effusive 
form and reflect the recycling of hemoglobin products derived by the leakage and destruction of 
erythrocytes in the effusions and lesions (Pedersen, 2009).  
More useful information for the diagnosis of FIP can be obtained from the analysis of serum 
proteins. One common finding is hyperproteinemia, generally caused by the increase of the γ-
globulins concentration. This finding, however, is common also in diseases other than FIP, and was 
found in low percentages of FIP cats when a large number of cases was analyzed (Paltrinieri et al., 
2002; Norris et al., 2005; Tsai et al., 2011; Riemer et al., 2015). One more consistent finding is the 
decrease of the albumin:globulin (A:G) ratio, which was described to have a greater diagnostic 
value in comparison with total proteins and γ-globulins concentration increase and, when lower 
than 0.8, a good predictor for FIP (Hartmann et al., 2003). The A:G ratio, however, must be 
considered in relation with the disease prevalence, since in a population with a low prevalence of 
FIP, the negative predictive value (NPP) is high, allowing to exclude the disease, while the positive 
predictive value is very low even at a cut-off of 0.6 (Jeffery et al., 2012). Other consistent findings 
are changes in the globulin concentrations and typical electrophoretic patterns since during FIP, 
both α2 and γ-globulins concentrations increase and the electrophoretogram usually reveals 
polyclonal hypergammaglobulinaemia as well as an increase in α2 fraction (Stoddart et al., 1988; 
Sparkes et al., 1991; Paltrinieri et al., 1998; Paltrinieri et al., 2001; Addie et al., 2009; Taylor et al., 
2010; Riemer et al., 2015). Hypergammaglobulinemia is not related to an increase of the 
antibodies levels but probably with the increase of some serum proteins with γ motility, probably 
complement factors, while the increase of the α2 fraction is due to the presence of high levels of 
acute phase proteins, mostly haptoglobin (Stoddart et al., 1988; Paltrinieri et al., 1998; Pedersen, 
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2009). A Recent study found an increase of the γ-globulin concentrations, manifested as polyclonal 
gammopathy, in most of FIP cats, while only a small percentage of cats showed an increase of the 
α2-globulins concentrations (Taylor et al., 2010).  
The acute phase protein α1-acid glycoprotein (AGP) is a very useful marker for the diagnosis of 
FIP. Extensive studies have been performed on its concentration in FIP cats and in cats from multi-
cat environments exposed to feline coronavirus after its increase was found in experimentally 
induced FIP (Stoddart et al., 1988; Duthie et al., 1997). When FIP appears in a multi-cat 
environment, there are fluctuations of acute phase proteins and especially of AGP in healthy cats, 
maybe as a sign of inflammatory response in reaction to the presence of FCoV mutants in the 
environment, while in cats that develop the disease, the AGP concentrations remain high 
(Giordano et al., 2004). Being a protein that can increase due to diseases other than FIP, the 
diagnostic value of AGP for FIP was assessed by several studies. According to Duthie et al. (1997), 
an AGP concentration of 1.5 mg/mL supports the diagnosis of FIP. A further study demonstrated 
that an AGP concentration of 1.5-2 mg/mL can be helpful in discerning between FIP and cats with 
other diseases when the anamnesis and clinical features are consistent with FIP, while a 
concentration above 3 mg/mL can support the diagnosis of FIP even if the pre-test probabilities 
are low (Paltrinieri et al., 2007). In a recent study, a small number of clinical challenging FIP cases 
was analyzed, and AGP was in perfect concordance with histopathology (Giori et al., 2011).  
Besides increased its concentrations, AGP is also hyposialylated in FIP cats compared with healthy 
cats or cats affected with other diseases, down-regulating in this way the phagocytic activity of 
feline neutrophils and probably contributing to the cell-mediated immune response deficit typical 
of FIP (Rossi et al., 2013). 
 
Analysis of effusions 
Effusions should always be evaluated, since tests on effusions have a higher diagnostic accuracy 
compared with tests on blood (Hartmann, 2005; Addie et al., 2009). FIP effusions are usually 
cloudy, yellowish and with egg-white consistency, often presenting fibrin clots or strands 
(Pedersen, 2014b). Protein content is high (>3.5 g/dL), while cellular content is variable, but 
usually low (<5000 white blood cells/µL). At cytology, a mixed population of not nerated 
neutrophils, lymphocytes, macrophages and mesothelials cells on a granular proteinaceous 
background is usually seen. Cytology has a good sensitivity but a moderate specificity, since the FIP 
pattern is common of non specific inflammatory processes (Paltrinieri et al., 1999). On the other 
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hand, in cats with diseases other than FIP it allows to quickly recognize septic or neoplastic 
effusions, therefore it should be always performed (Addie et al., 2004). The Rivalta’s test, a test 
developed a century ago and initially used to differentiate exudates from transudates in human 
body cavity effusions, may be useful to identify FIP effusions. In the presence of high protein 
concentrations and probably of inflammatory mediators typical of FIP, in fact, the effusions form a 
visible clot when added to an acetic solution. The Rivalta’s test diagnostic accuracy was recently 
re-discussed, and found lower than previously reported (Hartmann, 2005; Fischer et al., 2012). 
Moreover, the test is subjective and operator-dependent (Fischer et al., 2013). 
 
Serology 
The main issue with antibodies detection, is that FECV and FIPV are antigenically identical 
therefore causing the same antibody response (Pedersen, 2009). Therefore, FCoV-infected, 
healthy cats, can result positive at serological tests (Addie et al., 2009). Titers above 1:1.600, in 
combination with other findings suggestive of FIP, may increase the odds of diagnosing FIP. Cats 
from environments where the FCoV is endemic, however, may have high titers as well. Values 
above 1:3.200 are considered highly suggestive of FIP, but also in these cases serology should 
always be evaluated in combination with other tests (Hartmann et al., 2003; Hartmann et al., 
2005; Pedersen, 2014b). Another issue is the low sensitivity of serological tests. This finding was 
recently ascribed to the presence of high viral load that would bind the antibodies, making them 
no more available for the test. However, sera and effusions with low coronavirus antibody titers 
were positive at PCR, making this explanation not sufficient for the low sensitivity of serology (Meli 
et al., 2012).  
 
Viral detection 
Immunohistochemical demonstration of the antigen inside the lesions is considered the gold 
standard for the diagnosis of FIP (Tammer et al., 1995). There are, anyway, some cases where it 
can be falsely negative, depending on the quality of tissues, reagents and quantity of infected 
macrophages (Pedersen, 2014b). Immunochemistry can be performed also in vivo on biopsies or 
fine needle aspirates (FNAs), but the sensitivity is influenced by the type of sampling, the type of 
lesion and the cellularity. The sensitivity, however, can increase when biopsies and FNAs from the 
same tissue are considered together (Giordano et al., 2005). Immunocytochemistry or 
immunofluorescence on effusions have been always considered helpful to confirm the disease but 
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not to exclude it, since this test is influenced by the cellularity of the sample and by the amount of 
virus in the macrophages (Paltrinieri et al., 1999; Hartmann et al., 2003; Addie et al., 2004). Recent 
studies, however, have shown for these tests a specificity lower than previously reported, possibly 
due to the leakage, in presence of inflammation, of FCoV infected monocytes in the effusions 
(Litster et al., 2013; Felten et al., 2016).  
Polymerase chain reaction (PCR) is a direct test with undeniable usefulness for the detection of 
shedders when the test is performed on the feces (Addie et al., 2004). Nonetheless, its value for 
the diagnosis of FIP is still argument of debate. In fact, while the PCR on feces is known to have no 
diagnostic value for FIP, its application on body fluids has been recently discussed. PCR on 
cerebrospinal fluid (CSF) and on other body effusions has shown optimal specificity but a low or 
suboptimal sensitivity, showing this to be a good test to confirm FIP but not to exclude it 
(Pedersen et al., 2014b; Doenges et al., 2015; Longstaff et al., 2015; Doenges et al., 2016). It is also 
known that FIP cats may have low or absent viral load in blood, and only 44% of suspected FIP 
cases have been recently shown to be PCR positive on effusions (Herrewegh et al., 1995b; Addie et 
al., 2004; Soma et al., 2013). 
The spike protein gene sequencing proposed by Chang et al. (2012) has been recently described by 
Kipar and Meli (2014) as “one of the most diagnostic potential tool involving the direct virus 
detection” and it is currently used by some laboratories for the diagnosis of FIP, even though only 
two studies about its diagnostic accuracy have been published. In particular, the diagnostic 
accuracy of the sequencing aimed to detect the M1058L mutation was investigated on effusion 
samples. While in one study the specificity could have not been investigated, another study 
showed an absolute specificity. On the other hand, the sensitivity resulted similarly low (Felten et 
al., 2015; Longstaff et al., 2015). 
 
FIP management 
Therapies 
A large number of different therapies have been attempted over the years for the treatment of 
FIP, but to this day none has been proven effective. Three main approaches have been used: 
inhibition of viral replication, inhibition of the inflammatory response and non specific modulation 
of the immune system (Pedersen, 2014b). Viral encoded proteases that cleave viral polyproteins 
into functional single proteins are the target of recently discovered anti viral drugs. In a very 
recent study, a 3C-like (3CLpro) protease inhibitor that previously showed anti-FIPV in vitro was 
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tested in vivo in experimentally induce FIP. The treatment caused the regression of clinical 
symptoms and the reduction of viral load in macrophages from ascites in 6/8 cats (Kim et al., 2013; 
Kim et al., 2015; Kim et al., 2016). Three small molecule inhibitors (chloroquine, mefloquine, and 
hexamethylene amiloride) demonstrated a marked inhibitory effect on FCoV replication in vitro 
but not yet in vivo, except for chloroquine, which demonstrated some improvement in the clinical 
signs of FIPV infected cats, but caused hepatotoxicity at the same time (Takano et al., 2013; 
McDonagh et al., 2014). Human IFN-α and -β inhibit FIPV in vitro, and feline IFN-ω has the same 
effect without causing the production of antibodies against the molecule, as it happens with the 
human interferon (Hartmann et al., 2005). Feline IFN-ω was at first reported to induce remissions 
in the majority of FIP cats, but in a study involving a larger group of cats, IFN-ω showed no 
advantage effect in treating FIP (Ishida et al., 2004; Ritz et al., 2007). 
Prednisolone was and still is one of the classic treatment of choice when there is the suspicion of 
FIP, but it does not treat the disease (Addie et al., 2009). TNF inhibitors have been used to limit the 
inflammatory and pro-vasculitis effects of this cytokine, but with no difference neither in the 
survival time or in the amount of the effusions between treated and untreated cats (Fischer et al., 
2011). In a more recent study, the administration of anti-feline TNF-α monoclonal murine 
antibodies increased the survival time of 2/3 FIP experimentally induced cats. The cats, however, 
may develop anti-mouse antibodies causing an anaphylactic reaction, therefore the authors 
started to develop a mouse-feline chimeric antibody against TNF-α (Doki et al., 2016). 
A wide number of different immune stimulant compounds (staphylococcal A protein, 
Propriobacterium acnes, mucopolysaccharide extract of Aloe vera, a lymphocyte T cell 
immunomodulator and Polyprenyl immunostimulant) have been used, often off label and without 
evidence of a real benefit for the cat (Pedersen, 2014b). 
 
Prevention 
Due to the numerous failed attempts of developing an effective vaccine, the key for preventing FIP 
is to avoid FCoV infection through identification and isolation of the shedders and through the 
hygiene of the environment since the higher the proportion of shedding coronavirus at a given 
time, the more likely cats will develop FIP (Foley et al, 1997). Multi-cat environments (e.g. 
breeding catteries, shelters, multi-cat households) are undoubtedly high-risk environments, where 
infected cats can shed the virus for months or even life-long and where stress deriving from 
overcrowding or concurrent diseases is bigger (Addie et al., 2003; Pedersen, 2009). One way to 
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prevent FCoV infection is the strict quarantine of queens 2 weeks before birth and the separation 
and early weaning of kittens around 5-6 weeks of age, before the decrease of maternal antibodies. 
If kittens do not have antibodies at 12 weeks of age, they can be considered free from infection 
(Addie et al., 2004; Pedersen, 2009). This procedure, however, is not simple due to the strict 
control of exposure, to the costs for assuring enough free spaces for quarantine and for the 
potential problems of socialization associated with early weaning. Moreover, FCoV free kittens, 
could be easily become infected as soon as they are placed in another environment contaminated 
by FCoVs (Addie et al., 2004, Hartmann, 2005). 
Another method to control the infection is to separate the shedders from negative cats. Shedders 
can be detected with PCR on feces, but multiple testing every 2 weeks for two months or more is 
necessary due to the nature of FCoV shedding (Addie et al., 2001). An indirect way to identify the 
shedders is the antibody testing, since cats with low antibody titers (e.g., 1:25 or below) usually, 
but not always, are shedding very low or no virus, while cats with high antibody titers (e.g., 1:400) 
do. As with PCR, repeat testing is necessary to keep track of the intermittent shedders (Hartmann 
et al., 2005; Pedersen, 2014b).  
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Aims of the thesis 
The general aim of this thesis was to contribute to the development of new tests for the diagnosis 
intra-vitam of feline infectious peritonitis and feline coronavirus infections (including the 
collection of updated information regarding the diagnostic potential of pre-existing 
clinicopathological tests) and, to a lesser extent, to deepen some aspects of feline infectious 
peritonitis pathogenesis. 
Specific aims 
I. To determine the diagnostic accuracy of the Δ total nucleated cells (ΔTNC) measurement, which is 
the ratio between the two total nucleated cell counts (TNCC) in the DIFF and BASO channels of the 
hematology laser counter Sysmex XT-2000iV, for FIP effusions. The ΔTNC is based on the same 
principle of the Rivalta test, which is subjective and biased by several pre-analytical or analytical 
factors. The availability of a more objective approach such as the ΔTNC would improve the ability 
to correctly classify effusions as consistent with FIP. 
  
II. To determine if the ΔTNC measurement can be performed on supernatants of FIP effusions after 
the addition of feline blood and to assess the diagnostic accuracy of this method, as well as the 
influence of protein content, total cell count of the added blood and magnitude of dilution. The 
development of such a modified technique would in fact allow to investigate the ΔTNC also on 
frozen supernatants, thus allowing the collection of accurate diagnostic information also when 
samples cannot be immediately analyzed. 
 
III. To investigate the atypical serum electrophoretic (SPE) patterns recorded in FIP cats in the recent 
years and to compare them with SPE patterns from FIP and non FIP cats in a less recent time span. 
This information would be particularly useful since SPE is considered one of the most reliable tests 
to support a clinical diagnosis of FIP. However, anecdotal reports suggest that this diagnostic 
potential is diminished in recent years, due to the frequent occurrence of “false negative” results 
(i.e. electrophoretograms not consistent with FIP in cats actually affected by this disease). 
 
IV. To compare the diagnostic performances of clinico-pathological and molecular tests (in particular: 
SPE, α1-acid glycoprotein - AGP - measurement, RT-nPCR and spike gene sequencing on blood; 
cytology, evaluation of the ΔTNC, RT-nPCR 3’UTR and spike gene sequencing on cavitary effusions 
and RT-nPCR and spike gene sequencing on tissues specimens) for the ante-mortem diagnosis of 
FIP. The rationale of this comparison is that despite the numerous studies published in recent 
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years on each of these techniques, no studies have compared the diagnostic potential of the 
different tests. This information would be extremely useful to know the clinical scenarios on which 
each of the test may provide the most reliable diagnostic information. 
 
V. To develop a reverse transcriptase loop mediated isothermal amplification (RT-LAMP) for the 
detection of FCoV in the specimens most frequently used in clinical practice for both screening and 
diagnostic purposes. This method is more rapid and cheap than conventional PCR and therefore it 
would facilitate the extensive use of molecular techniques to investigate the presence of 
coronavirus genomes in different clinical specimens. 
 
VI. To sequence a wide number of FCoVs obtained from different specimens (tissues, body fluids, 
feces) of histochemically confirmed FIP and non-FIP cats and to better understand the correlation 
between the spike gene mutations described by Chang et al. (2012) and FIP development. 
Sequences of viral strains collected from cats with and without FIP are widely investigated in 
recent times but often performed on a limited number of samples. The rationale of this specific 
aim is that any additional information on the genomic variability of viral strains may be relevant in 
terms of basic knowledge of host-virus interaction. 
 
VI.1. To assess possible differences in the frequency of FCoV shedding in cats affected or non 
affected by FIP, and to investigate any spike protein mutations present. Also in this case, this 
information would enrich the currently available information on the characteristics of viral 
shedding and it may be a preliminary step for future studies on the development of diagnostic 
tests or of tests potentially applicable in pathogenic studies. 
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I. High diagnostic accuracy of the Sysmex  XT-2000iV delta total nucleated cells on 
effusions for feline infectious peritonitis 
 
Material and methods 
Case selection 
This retrospective study was performed on data obtained from effusions submitted for diagnostic 
purposes and under informed consent of the owners to the Department of Veterinary Medicine of 
the University of Milan (DIMEVET). Feline intracavitary effusions analyzed with the Sysmex XT-
2000iV from June 2009 to June 2013 were selected from the DIMEVET database and used for data 
analysis if fulfilling the criteria reported in the following table 1. 
Inclusion criteria Exclusion criteria 
Available complete documentation of physico-
chemical analysis of the effusion 
Absence of follow-up 
Available extensive information about the final 
diagnosis 
Absence of cytologic information 
Available cyto-centrifuged slides in the archive of 
DIMEVET for those cases where no cytologic report 
was available 
Absence of slides to verify the cytologic pattern in 
cases without cytology report in the database. 
 
 
Unclear or non-conclusive cytologic findings in 
cases with archived slides but without information 
in the database 
Table 1.  Inclusion and exclusion criteria used for this study.  
Cats were defined as FIP if histopathology was consistent with FIP and if immunohistochemistry 
against FCoV was positive. Cats were considered as non-FIP if another disease was diagnosed 
through effusion analysis, eventually confirmed by necropsy and histology, or for clinical 
improvement after treatment. 
 
Sysmex XT-2000iV 
Only effusions collected in EDTA tubes and submitted no later than 12–18 hours after sampling 
were analyzed on the Sysmex XT-2000iV (Sysmex EuropeGmbH, Norderstedt, Germany) analyzer 
to determine TNCC provided by both the DIFF (TNCC-DIFF) and BASO (TNCC-BASO) channels, as 
well as the ΔTNC. Specifically, the DIFF channel classifies all nucleated cells based on complexity 
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and nucleic acid content. The BASO channel classifies nucleated cells based on volume and the 
complexity of cellular residues produced after contact with an acidic reagent that, in human blood, 
condenses all the nucleated cells except basophils (Lilliehook and Tvedten, 2011). Since effusions 
include cells other than WBC, the total WBC count and the ΔWBC generated by the instrument 
were defined as TNCC and ΔTNC.  
 
Statistical analyses 
The Analyse-it software (Analyse-it Software Ltd, Leeds, UK) was used. A nonparametric t-test 
(Mann–Whitney U-test), using the 95% confidence interval (CI) as a measure of uncertainty was 
used to compare to each other TNCC-DIFF, the TNCC-BASO, and ΔTNC results from FIP and non-FIP 
cats. To assess the diagnostic accuracy of ΔTNC, the number of true positive (TP), false-positive 
(FP), true-negative (TN), and false-negative (FN) results were calculated as follows: TP, effusions 
from FIP cats with a ΔTNC higher than each operating point; TN, effusions from non-FIP cats with a 
ΔTNC lower than each operating point; FP, effusions from non-FIP cats with a ΔTNC higher than 
each operating point; and FN, effusions from FIP-cats with a ΔTNC lower than each operating 
point. Sensitivity and specificity were calculated using standard formulas and using the 95% CI as a 
measure of uncertainty (Christenson, 2007). Positive and negative likelihood ratios (LR+ and LR-, 
respectively) were calculated using the formulas: LR+= sensitivity/(1-specificity) and  
LR- = (1-sensitivity)/specificity, respectively (Gardner and Greiner, 2006). 
Finally, receiver operating characteristic (ROC) curves were designed by plotting sensitivity vs 1-
specificity to determine the discriminating power of ΔTNC in identifying cats with FIP (Gardner and 
Greiner, 2006). The optimal cut-off value was identified as the operating point closer to the upper 
left corner of the graph.  
 
Analytical precision and accuracy 
Since there is no information about repeatability and linearity under dilution of Sysmex readings of 
TNCC-DIFF and TNCC-BASO of effusions from cats with FIP, in the current study, repeatability was 
assessed on 2 FIP samples with a high ΔTNC and on 2 specimens with a normal ΔTNC in 5 
consecutive measurements on one day, and by calculating the CV with the formula: CV= mean/SD 
x 100. To assess linearity under dilution, one specimen with high and one with normal ΔTNC were 
each serially diluted at 1:1, 1:3, 1:7, and 1:15 (vol/vol) with isotonic saline, resulting in dilutions 
corresponding to 50%, 25%, 12.5%, and 6.25% of the original effusion, respectively. After being 
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analysed on the Sysmex, linearity was determined by comparing the expected values for each 
dilution to the values provided by the instrument in a linear regression analysis. 
 
Results  
Retrospective study population and distribution of cases per group 
The results of the retrospective search are reported in figure 1. The 51 selected effusions were 
grouped as follows: 
Group A, FIP (20 cats). In all these cases except 2, the physico-chemical features and cytology of 
the effusions were consistent with FIP. The 2 cases of FIP with “atypical” findings in the effusion 
included cat 5 with polyclonal gammopathy and very high serum AGP concentration, but an 
effusion with a low protein concentration (17 g/L), low specific gravity (1.010), and low cellularity 
(0.13x109/L), with rare neutrophils and mesothelial cells in the absence of the typical 
proteinaceous background. The pericardial effusion of cat 25 revealed a high number of reactive 
mesothelial cells, sometimes with evident cytophagia and a weakly proteinaceous background. 
However, in all the 20 cases, the diagnosis of FIP was confirmed by histology and by the 
immunohistochemical detection of intralesional FCoV.  
 
 
 
Figure 1. Inclusion and exclusion criteria adopted for the selection of cases from the database and 
the final assignment to the study groups. 
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Group B, non-FIP (31 cats). Details about the diagnosis of each cat are reported in table 2. 
 
Unfortunately, the non-FIP group contained a high number of neoplastic effusions that were not 
as challenging for a differential diagnosis from FIP, being easily recognizable by cytology.  
 
Type n° Subtype Diagnosis 
Tumours 
(20) 
10  Lymphomas Cytology and imaging 
8 Epithelial tumors Cytology and imaging 
1 Thymoma Cytology and imaging 
1 Hemangiosarcoma Cytology, imaging, PM, histology 
Inflammatory 
(5) 
3 Septic Bacteriology 
2 Cholangiohepatitis Laboratory findings 
Chylous 3 Heart failure Cytology and imaging 
Modified transudate 
(3) 
2 Abdominal neoplasia PM, histology 
1 Cardiomyopathy Imaging, remission after treatment 
Table 2. Subdivision of the non FIP effusions in the different subtypes and diagnostic methods  
adopted. PM: post mortem examination. 
 
 
Repeatability and linearity under dilution 
Repeatability of specimens with normal ΔTNC was better for both DIFF and BASO counts as well as 
for ΔTNC, with CV < 2.56%. Conversely, CV was higher and extremely variable for the specimens 
with high ΔTNC, due to a high variability in both BASO and DIFF counts (table 3). Linearity under 
dilution provided excellent results for TNCC-DIFF and TNCC-BASO of the specimens with normal 
ΔTNC, with correlation coefficients of 0.99 and 1.00, respectively (P < 0.001). Consequently, ΔTNC 
remained constant over the different dilutions. Conversely, the linearity under dilution of 
specimens with high ΔTNC was satisfactory only for DIFF-TNCC (table 4, figure 2,3).  
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 Repeatability 
 Cat #1 (FIP) Cat # 2 (FIP) Cat # 2 (lymphoma) Cat # 4 (Inflammation) 
 DIFF BASO ∆TNC DIFF BASO ∆TNC DIFF BASO ∆TNC DIFF BASO ∆TNC 
Run 1 1.47 0.11 13.364 0.72 0.09 8.000 5.59 5.58 1.002 12.41 11.98 1.036 
Run 2 2.01 0.13 15.462 0.81 0.05 16.200 5.48 5.66 0.968 12.19 12.04 1.012 
Run 3 2.05 0.12 17.083 0.74 0.05 14.800 5.58 5.55 1.005 12.62 12.04 1.048 
Run 4 2.14 0.14 15.286 0.79 0.07 11.286 5.57 5.63 0.989 12.59 11.96 1.053 
Run 5 2.45 0.12 20.417 0.78 0.07 11.143 5.36 5.67 0.945 12.54 12.21 1.027 
Mean 2.02 0.12 16.32 0.77 0.11 12.29 5.52 5.62 0.98 12.47 12.05 1.04 
SD 0.35 0.01 2.64 0.04 0.02 3.25 0.10 0.05 0.03 0.18 0.10 0.02 
CV (%) 17.52 9.19 16.18 4.82 15.21 26.47 1.77 0.92 2.56 1.41 0.82 1.57 
Table 3. Results regarding repeatability recorded in two cats with high ΔTNC associated with FIP and in two 
cats with normal ΔTNC. 
 
 Linearity under dilution 
 Cat # 2 (FIP) Cat # 2 (lymphoma) 
 DIFF BASO ΔTNC DIFF BASO ΔTNC 
Undiluted 0.97 0.11 8.818 5.67 5.53 1.025 
50% 0.48 0.1 4.800 2.54 2.54 1.000 
25% 0.2 0.11 1.818 1.05 1.16 0.905 
12.5% 0.21 0.1 2.100 0.67 0.73 0.918 
6.25% 0.12 0.12 1.000 0.34 0.4 0.850 
Table 4. Results regarding linearity under dilution recorded in a cat with high ΔTNC associated with FIP and 
in a cat with normal ΔTNC. 
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Figure 2. Linearity under dilution (LUD) recorded in serially diluted effusion specimens from a cat with 
lymphoma (A, DIFF-TNCC; B, BASO –TNCC; C, ΔTNC). Values on the y-axes refers to observed values, while 
values on the x-axes refers to expected values. 
 
 
 
Figure 3. Linearity under dilution (LUD) recorded in serially diluted effusion specimens from a cat with FIP 
(A, DIFF-TNCC; B, BASO –TNCC; C, ΔTNC). Values on the y-axes refers to observed values, while values on 
the x-axes refers to expected values. 
 
 
Comparison of TNCC-DIFF, TNCC-BASO, and ΔTNC between cats with and without FIP 
 
The TNCC-BASO and TNCC-DIFF counts were significantly lower (P < 0.001 and P < 0.05, 
respectively) in cats with FIP (TNCC-BASO = 0.2; 0.0–5.3; TNCC-DIFF = 1.5; 0.1–26.3) than in non-
FIP cats (TNCC-BASO = 10.1; 0.0–707.9; TNCC-DIFF = 9.1; 0.1–921.8; Figure 4), with a high inter-
individual variability in the latter group, likely due to the heterogeneity of the diseases. The ΔΤΝC 
was significantly higher (P < 0.001) in cats with FIP (median: 9.3; min–max: 0.5–36.4) than in non-
FIP cats (1.0; 0.5–2.5).  All the cats with FIP had a ΔTNC > 3.0, except for the 2 “atypical” FIP 
effusions (cat 5, ΔTNC 0.538; cat 25, ΔTNC 1.165). One of the cats showing “atypical” FIP effusion 
had hypoalbuminemia and a hemorrhagic syndrome, which are changes with liver failure that may 
induce also hypofibrinogenemia, likely preventing clotting in the BASO reagent. In the other case, 
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the cytologic pattern of the effusion was complicated by the presence of “atypical” mesothelial 
cells that are usually not abundant in FIP effusions. In both cases, the false-negative results of 
ΔTNC may be related to atypical features of the effusion rather than the low analytical sensitivity. 
All non-FIP cats had a ΔTNC < 3.0. More specifically, the only 2 specimens from all 31 cats without 
FIP with a ΔTNC > 1.7 but < 3.0 were a cat with lymphoma and a highly cellular effusion (TNCC-
DIFF: 25.45 cellsx109/L), and an almost non cellular modified transudate from a cardiopathic cat 
(TNCC-DIFF: 0.05 cellsX109/L). Lymphomas can sometimes provide positive Rivalta’s test results in 
people (Sakai et al., 2004) while the high ΔTNC in the second case, was clearly a mathematical 
artifact due to the analytical sensitivity of the instrument. 
These results demonstrate that cells are entrapped in clots formed by fibrinogen precipitation in 
the BASO channel, therefore cell counts in the BASO channel are usually lower than those of the 
DIFF channel. This mechanism explains why the ΔTNC (in the Sysmex referred to as ΔWBC) 
increases in such specimens. 
 
Diagnostic accuracy of ΔTNC 
The area under the ROC curve for ΔTNC (figure 5) was 0.94 (95% CI = 0.84–1.00, P < 0.001 
compared with the line of no discrimination). The best cut-off for ΔTNC determined by the ROC 
curve analysis was 1.7. At this value, sensitivity was 90.0% (95% CI = 68.3–98.8%), specificity was 
93.5% (95% CI = 78.6–99.2%), LR+ was 13.9 (95% CI = 4.6–86.3), and LR- was 0.11 (95% CI = 0.0–
0.3). When using a cutoff of ΔTNC = 2.5, specificity increased to 100%.  Thus, ΔTNC has a high 
diagnostic accuracy for FIP.  Specifically, a ΔTNC > 1.7 makes it 14 times more likely that an 
effusion originates from a cat with FIP rather than a different disease. Conversely, with a ΔTNC 
 < 1.7, the probability that the effusion comes from a cat with FIP is about one-tenth of the 
probability that the effusion comes from a cat with a different disease.  
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Figure 4. Values of TNCC-DIFF (A), TNCC-BASO (B), and the ratio between total nucleated cell counts in the 
DIFF and BASO channel of Sysmex XT-2000iV, reported as ΔWBC by the instrument but termed ΔTNC in this 
study (C) recorded in cats FIP and non-FIP cats. The boxes indicate the I–III interquartile range (IQR), the 
horizontal line indicates the median, whiskers extend to within the I quartile minus 1.5*IQR or to within the 
III quartile plus 1.5*IQR. Dots indicate the values recorded in this study. The TNCC-DIFF and the TNCC-BASO 
graphs do not include the result of a neoplastic non-FIP specimen that had extremely high TNCC-DIFF and 
TNCC-BASO counts (921.8 and 707.9 cells x 109/L). The black bolded asterisks reported below the X-axis 
indicate a significant difference between groups (*P < .05; ***P < .001). 
 
  
 
 
 
 
 
Figure 5. Receiver operating 
characteristic (ROC) curves of the ratio 
between total nucleated cells in the DIFF 
and BASO channel of Sysmex XT-2000iV, 
reported as ΔWBC by the instrument but 
termed ΔTNC in this study, for the 
diagnosis of FIP.  
The gray line indicates the line of no 
discrimination. 
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Discussion 
The results of the current study suggest that the instrumental analysis with the Sysmex XT-2000iV 
may represent an additional reliable method for confirmation of FIP in the analysis of effusions.  
A possible limitation of this study was the low number of non neoplastic effusions that in routine 
practice may benefit from an additional test to distinguish FIP from other types of inflammatory or 
reactive effusions. However, also in a previous feline effusions study, all the specimens from cats 
with inflammatory effusions other than FIP had a ΔTNC < 1, confirming that a ΔTNC > 1 has a high 
diagnostic accuracy for FIP (Pinto da Cunha et al., 2009). 
Independently on the few FN and FP cases, the analysis of effusions with the Sysmex XT-2000iV 
counter evidenced a sensitivity and a specificity comparable to or even higher than that previously 
reported for the Rivalta’s test (Fischer et al., 2012). Moreover, the Rivalta’s test is rapid, cheap, 
and accurate, but it may be limited due to inappropriate techniques or intrinsic factors of the 
reagents such as concentration of acetic acid, different temperatures of the effusion, 
and the acetic acid solution (Fischer et al., 2013). Additionally, the Rivalta’s test provides semi-
quantitative results and does not allow grading the severity of the change. Finally, the evaluation 
of the test is subjective and a high inter-observer variability is observed (Fischer et al., 2013). 
Conversely, the analysis with the Sysmex XT-2000iV counter is more standardized and rapid and 
provides, in addition to the cell count, a provisional information on the cell types based on the 
scattergram (Pinto da Cunha et al., 2009). However, it must be stressed that the linearity under 
dilution test performed in this study demonstrated that the more accurate cell count provided by 
the instrument is the DIFF-TNCC, which is not affected by the entrapment of cells in the clots 
formed after contact with the BASO reagent. Therefore, in routine practice, it is not recommended 
to use the default WBC counts that are generated by the BASO channel. Precision and linearity 
were not satisfactory at high ΔTNC values. However, this does not affect the clinical decision since 
the difference between ΔTNC values recorded in cats with and without FIP was higher than the 
imprecision or bias of the method.   
In conclusion, this study evidenced a very high diagnostic accuracy of the Sysmex-generated ΔTNC, 
where values > 1.7 are highly suggestive of FIP, and a ΔTNC > 3.4 which, although higher than the 
cut-off with the maximum specificity recorded in this study, was the threshold confirmatory for FIP 
in a previously published study (Pinto da Cunha et al., 2009), may be considered diagnostic for FIP. 
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II. Diagnosing feline infectious peritonitis using the Sysmex XT-2000iV based on 
frozen supernatants from cavitary effusions  
 
Material and methods 
Thirty-four feline effusions were collected for diagnostic purposes and submitted to the DIMEVET 
laboratory according to standard veterinary procedures, therefore without the need of a formal 
approval of the Institutional Ethical Committee. 
Nineteen effusions were classified as FIP based on post mortem histology and 
immunohistochemistry (18/19) or through histology and immunohistochemistry of biopsies (1/19). 
FIP was excluded based on postmortem findings in 5 of the 15 cats without FIP. These 5 cats were 
diagnosed with pleuropericardial chronic fibrosis (cat 20), pleural undifferentiated pleomorphic 
sarcoma (cat 21), abdominal hemangiosarcoma (cat 24), undifferentiated liver neoplasia (cat 27), 
and acute leukemia (cat 33). In 4/15 cats without FIP, a diagnosis of neoplasia was obtained 
through cytology (cats 22, 23, 30, 34) and confirmed through histology (cats 30, 34). In the 
remaining 6 of 15 cats without FIP, the following diagnoses were obtained in vivo:  cats 25 and 29 
were diagnosed with cardiomyopathy and cat 32 with pancreatitis, all responding to the specific 
treatment. Cats 26, 28, and 31 were diagnosed with chylothorax through cytology and diagnostic 
imaging. 
Twenty-seven samples were collected in EDTA tubes and analyzed with the Sysmex XT-2000iV 
within 12–18 h. After the ΔTNC measurement, the effusions were centrifuged (3,000 × g, 5 min) 
and the supernatants transferred to other tubes and frozen at –20°C (~1–8 weeks). Seven samples 
(1, 10, 16, 18, 19, 28, 29) were centrifuged by the referring veterinarians, and the supernatants 
sent to our laboratory where immediately frozen (~1–8 weeks). 
Twenty μL of fresh feline blood (ΔWBC of 1.00 ± 0.15; mean ± standard deviation), obtained from 
the routine caseload of the DIMEVET laboratory, were added to 180 μL of thawed supernatants to 
obtain a dilution of 1:10 (figure 1).  
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Figure 1. Procedure for the evaluation of the modified ΔTNC measurement. A. collection of the effusion in 
EDTA tubes. B. Centrifugation of the sample followed by the removal of the supernatant. C. Freezing 
and thawing of the supernatant in a other tube. D. Addition of feline blood in a 1:10 dilution. 
 
 
 
 
Specifically, 15 different blood samples were used (WBC counts: 5.11–154 × 109 WBC/L). Each 
blood sample was used to spike 1–4 effusions (Table 1).  
After gentle mixing, the samples were analyzed with the Sysmex XT-2000iV. WBC-DIFF and WBC-
BASO counts and ΔTNC were recorded. Samples were then classified as positive or negative using 
a ΔTNC of 1.7 and a ΔTNC of 3.4 as cut-offs. Using both the cut-offs and based on the final 
diagnosis (FIP vs. non-FIP), the numbers of TP, TN, FP, or FN results were counted. Specificity, 
sensitivity, positive predictive value (PPV), and negative predictive value (NPV) were then 
calculated. 
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Added blood 
sample 
WBC count in added blood  
(× 109/L) 
FIP effusion cats Non-FIP effusion cats 
1 5.1 2, 4, 6, 7  
2 11.4 13  
3 13.0 
 
29 
4 13.4 3, 18 21, 22 
5 14.1 19 26, 27, 34 
6 15.3  33 
7 19.4 16 20, 28 
8 20.1 14 32 
9 26.8 9  
10 34.1 17  
11 36.2  25 
12 39.9 1, 5, 10, 15  
13 44.6 11, 12  
14 65.0 8 23, 24 
15 154  30, 31 
Table 1. White blood cell (WBC) counts of the 15 blood samples added to the effusions of the 34 cats 
included in the study. 
 
Results and discussion 
The addition of blood did not generate a matrix effect that interfered with the cell counts, as 
demonstrated by the fact that the WBC-DIFF in the effusion was close to 10% of the added blood 
cell count, as expected using the 1:10 dilution (10.9 ± 1.2 in the whole caseload; 11.1 ± 1.2 in FIP 
effusions; 10.8 ± 1.2 in non-FIP effusions). This was found in all the cases but one, were the WBC-
DIFF count recorded in the effusions added with blood was 24.6% compared with the WBC count 
in blood.  
In 12 of 27 cases that were analyzed with both methods (cats 2–4, 6, 7, 13, 15, 17, 21, 31, 32, 34), 
the modified ΔTNC was lower than the original one (Fig. 2). 
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Figure 2. Results of the delta total nucleated cells (ΔTNC) on fresh effusions with the original method 
(white bars) and on frozen–thawed supernatants using the modified method described in this study (gray 
bars) in cats with feline infectious peritonitis (cats 1-19) or without FIP (cats 20-34). The horizontal dashed 
black line and the horizontal dotted line indicate the cutoffs that have been defined, respectively, as 
“suggestive for FIP” (1.7) and “consistent with FIP” (3.4) in the previous study. 
* Effusions in which the WBC-DIFF count was lower in the modified method than in the original method. 
† Eﬀusions in which the WBC-DIFF count was higher in the modified method than in the original method. 
‡ Eﬀusions in which the WBC-DIFF count was unchanged in the modified method compared with the 
original method. 
 
In 8 of these cases, the WBC-DIFF count resulted from the addition of blood, was lower than in the 
fresh sample. Conversely, in 6 of 27 cases (cats 5, 9, 11, 12, 14, 26), the modified ΔTNC was higher 
than the original, and in 3 of these cases the WBC-DIFF count was higher than that of the fresh 
sample. In 9 of 27 cases (cats 8, 20, 22–25, 27, 30, 33), 8 of which belonged to the non-FIP group, 
the modified ΔTNC remained unchanged compared with the original ΔTNC (<10% variation 
compared with the original ΔTNC), despite the WBC-DIFF count being higher in 6 of these cases 
compared with the fresh sample. Therefore, the modified method induced variations of the ΔTNC 
in approximately two-thirds of samples (16 of 27 cases). 
Results obtained with the 2 methods were compared using a Wilcoxon signed rank test, and no 
significant differences were recorded, suggesting that frozen supernatants provide results similar 
to fresh samples (figure 3).  
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Moreover, the increase or decrease of the ΔTNC does not seem to be proportional to the values of 
the WBC-DIFF counts recorded after mixing blood with supernatants; in approximately one-third 
of samples, the ΔTNC did not change, despite a marked difference between the WBC-DIFF count of 
fresh samples and the WBC-DIFF count recorded after mixing blood with the supernatants. This 
suggests that the final WBC-DIFF count obtained after dilution does not directly influence the 
ΔTNC. The design of our study does not allow to determine the number of WBCs needed in a feline 
blood sample to optimize the test. However, the fact that effusions added with the same blood 
sample often had different ΔTNC values, supports the hypothesis that the ΔTNC is influenced by 
the type of effusion rather than by the cell count of the added blood. However, it is possible that 
blood samples with leukopenia, not included in our study, lead to a WBC-DIFF count in the 
effusion so low as to hamper the possibility of having, in FIP cats, a ΔTNC sufficiently high to 
Figure 3. Comparison of results 
obtained in fresh effusions processed 
with the original method or in frozen 
effusions using the modified method 
(A and B) or in frozen samples with 
different blood effusion ratios (C and 
D). The ∆TNC recorded in cats with FIP 
are reported in A and C; The ∆TNC 
recorded in cats without FIP are 
reported in B and D. 
The boxes indicate the I–III 
interquartile range (IQR), the 
horizontal line indicates median 
values, whiskers extend to further 
observation within the I quartile minus 
1.5xIQR or within the III quartile plus 
1.5xIQR. 
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support a clinical diagnosis of FIP. Hence, the use of leukopenic blood samples to spike frozen 
effusions cannot be recommended based on our results. 
In order to assess the effect of dilution, 9 samples (4 from cats with FIP and 5 from cats without 
FIP) were tested using 2 dilutions of blood: 1:10, as described above, and 1:5 (i.e., 40 μL of blood 
in 160 μL of supernatant). Also in this case, no significant differences were found with the 2 
dilutions either in the FIP group or in the non-FIP group, and the classification of samples as 
consistent or not consistent with FIP did not change at the 1:5 dilution compared with the 1:10 
dilution (figure 4).  
 
 
The 4 FIP effusions were also analyzed using a 1:2 dilution (100 µL of blood in 100 µL of 
supernatant) and, even though no significant differences or changes in the classification of 
samples were found in this comparison, the ΔTNC decreased in all 4 cases (from 12.6 to 7.7, from 
4.10 to 1.22, from 4.75 to 0.74, from 0.98 to 0.97 in a 1:10 and 1:2 dilution, respectively). These 
data suggest that when the supernatant:blood ratio is low, the amount of fibrin (and other 
inflammatory proteins) is too low to induce cell clumping given the dilution of proteins responsible 
for WBC clumping. Therefore, the 1:5 and 1:10 dilution provide similar results, and the 1:10 
dilution should be preferred to facilitate the calculation of volumes. 
The total protein content of the effusions was high independently on the final diagnosis (2.7 to 6.0 
g/dL in non FIP effusions; 3.3 to 7.2 g/dL in FIP effusions) hence it did not influence the ΔTNC 
values with either the original or the modified method, suggesting that it is not the overall amount 
of protein that is responsible for the increased ΔTNC, but rather the presence of a particular 
protein pattern. Using the 1:10 dilution, independently of the differences in ΔTNC values between 
fresh and frozen–thawed samples, all the effusions from cats without FIP had a ΔTNC <1.7 using 
Figure 4. Comparison of the results 
obtained in frozen-thawed samples 
with different blood effusion ratios. 
The ΔTNC recorded in cats with FIP are 
reported in A, while the ΔTNC recorded 
in cats without FIP are reported in B. 
 
The boxes indicate the I–III 
interquartile range (IQR), the horizontal 
line indicates median values, whiskers 
extend to further observation within 
the I quartile minus 1.5xIQR or within 
the III quartile plus 1.5xIQR. 
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both methods. Conversely, on fresh effusions from cats with FIP, 4 of 14 samples (cats 2, 8, 9, 17) 
had a ΔTNC <1.7, 3 of 14 samples (cats 11–13) had a ΔTNC of 1.7–3.4, and 7 of 14 samples (cats 3–
7, 14, 15) had a ΔTNC consistent with FIP (>3.4). Using the modified technique, 2 of the 4 “false-
negatives” (ΔTNC <1.7; cats 2, 8) remained falsely negative, 1 of 4 (cat 17) increased to values 
suggestive of FIP (ΔTNC of 1.7–3.4), and 1 of 4 (cat 9) resulted as positive (ΔTNC >3.4). Only 1 true-
positive sample based on the fresh sample (cat 13; which, however, had a ΔTNC of 1.89, close to 
the lowest cutoff of 1.7) resulted as a false-negative (ΔTNC <1.7) using the modified technique. 
The 2 other samples that on fresh effusions had a ΔTNC of 1.7–3.4 (cats 11, 12) resulted as positive 
(ΔTNC >3.4) using the modified technique. Therefore, in cats with FIP, using the modified 
technique, 3 of 19 samples (cats 2, 8, 13) had a ΔTNC <1.7, 1 of 19 (cat 17) had a ΔTNC of 1.7–3.4, 
and all the other samples had a ΔTNC >3.4. Hence, both methods, independently of the cutoff, 
show absolute specificity and PPV (100.0%). The sensitivity and NPV of the modified method 
(84.2% and 83.3% at the cutoff of 1.7; 78.9% and 78.9% at the cutoff of 3.4) were higher than that 
of the original method (78.6% and 81.3% at the cutoff of 1.7; 57.1% and 68.4% at the cutoff of 
3.4). Thus, the diagnostic interpretation of ΔTNC using the cutoffs that in study I were considered 
suggestive of FIP (ΔTNC >1.7) or consistent with FIP (ΔTNC >3.4) indicates that the modified 
method minimally affects the classification of samples as “FIP” or “non-FIP,” independently of the 
ΔTNC value obtained from fresh samples. Three samples from cats with FIP had a low ΔTNC count 
either with both the techniques, probably due to intrinsic properties of the effusions, as noted in 
the previous study. Thus, if the ΔTNC is negative using both methods, FIP must be confirmed using 
tests other than the ΔTNC. 
The results of our study demonstrated that the modified ΔTNC is an alternative, reliable tool to 
diagnose effusive FIP in those cases where cytology of the effusion or other biochemical tests on 
the supernatants cannot be performed immediately after sampling. This method can be 
performed on frozen supernatants, thus allowing retrospective analyses of stored fluids. 
Supernatants from FIP effusions, likely because of their protein pattern, retain the ability to clump 
cells derived from blood samples, whereas the non-FIP effusions do not. Therefore, it may be best 
to centrifuge effusions that cannot be analyzed immediately, and to remove and send the 
supernatant to the laboratory. Future studies focused on determining the minimum number of 
WBCs needed to obtain a positive result may further improve the performance of this alternative 
method. 
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III. Frequency of electrophoretic changes consistent with feline infectious 
peritonitis in two different time periods (2004-2009 vs 2013-2014) 
 
Material and methods 
Retrospective search of the database 
The database of the DIMEVET laboratory was retrospectively analysed. All the results of serum 
protein electrophoresis, either data referred to capillary zone electrophoresis (CZE) or data 
referred to agarose gel electrophoresis (AGE), performed between 2004 and 2014 were 
downloaded in an Excel sheet for the following selection procedures. Results referred to the two 
electrophoretic techniques were separately analysed. 
 
Electrophoretic methods and groups formation 
Agarose gel electrophoresis and capillary zone electrophoresis were performed using automated 
systems and kits provided by the manufacturer of the instruments, Hydrasis and Minicap 
respectively (Sebia Italia Srl, Bagno a Ripoli, Florence, Italy). For AGE, after 10 μl of each serum 
sample were manually loaded in the applicator, a 0.8% agarose gel was run in trisbarbital buffer at 
pH 8.6, with a migration time of 7 mins at 20 W Gels were then dried (10 mins at 65°C), 
automatically stained with Amido Schwarz, destained and dried again for scanning by the 
appropriate gel scanner. For CZE, serum samples were aspirated from the anode end of a silica 
capillary; proteins were then separated at 35°C by migration for 2.5 mins at high voltage 
(9000 V) in an alkaline buffer (pH 9.9). For AGE, data were then transferred to the software 
(Phoresis, Sebia Italia Srl) which analyses the density of each band, creating a corresponding peak, 
and separates each fraction based on the slopes of the curves. For CZE, variations of absorbance 
due to the protein flow were read through a spectrophotometer at 240 nm wavelength and 
recorded in real time by the software program (Phoresis) producing the typical electrophoretic 
peaks. 
For both the techniques, albumin, α1-, α2-, β1-, β2- and γ-globulin fractions were generated. For the 
purpose of this study, only data regarding electrophoretic fractions important for the diagnosis of 
FIP (total protein, albumin, α2-, and γ-globulin, total globulin and A/G ratio) were recorded and 
statistically analyzed. Absolute protein concentrations (g/dL) for each electrophoretic fraction 
were calculated based on the percentage of the area under each peak and on total serum protein 
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concentrations measured through an automated spectrophotometer (Cobas Mira, Roche) using 
the biuret method, except for 6 cases (5 processed with AGE and 1 with CZE), on which total 
proteins were not measured. In these cases, only the percentages of the different fractions were 
included in the statistical analysis. 
Data regarding SPE were divided in two groups:  
FIP: cats with necropsy and histology consistent with FIP and with intralesional coronaviruses 
detected by immunohistochemistry, 
Healthy cats: samples included in this group were submitted for annual wellness visits or for 
preoperative examinations or were included as a control group in previous studies and had 
unremarkable clinical or laboratory findings (Paltrinieri et al., 2014a; Paltrinieri et al., 2014b).  
 
Statistical analysis 
Statistical analysis was performed in an Excel (Microsoft Corp, Redmond, WA, USA) spreadsheet 
using the Analyse-it v-2.1 software (Analyse-it Software Ltd, Leeds, UK). 
Results obtained in the two time spans (2004-2009 vs 2013-2014) from FIP and healthy cats were 
compared to each other using a nonparametric t-test for independent measurements (Mann 
Whitney U test). The significance level was set at p<0.05. 
For the two time periods examined in this study, the number of cats from the FIP group showing 
single or combined electrophoretic changes consistent with FIP was counted (Pedersen, 2009; 
Giordano and Paltrinieri, 2010). To this aim, the relative and absolute value of the electrophoretic 
parameters listed above (expressed as percentage and g/L respectively) were compared with the 
reference intervals described in a previous study for AGE and CZE, respectively (Giordano and 
Paltrinieri, 2010).  
In addition, each electrophoretogram obtained from FIP cats underwent a visual analysis 
performed by two operators in a blind manner. Electrophoretograms were interpreted as 
“consistent with FIP” if showing both α2- and γ-globulin polyclonal peaks; as “dubious” if showing 
only one of the mentioned peaks and as “not consistent with FIP” if α2- and γ-globulin polyclonal 
peaks were both absent or if alterations typical of other diseases (e.g. monoclonal gammopathy) 
were detected (figure 1). In the case of disagreement between the classification of the 
electrophoretograms by the two observers, each electrophoretograms were evaluated as a man to 
reach a final consensual interpretation.  
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Both the comparison with reference intervals and the visual analysis were used to calculate the 
number of FIP cats with electrophoretic pattern consistent with FIP in order to calculate the 
sensitivity of the method. 
A Pearson chi-square analysis was used to evaluate the possible differences in the proportion of 
changes consistent with FIP either in terms of relative or absolute changes compared with the 
reference values and in terms of visual analysis. 
 
Figure 1. Examples of electrophoretograms considered (A, D) not consistent with feline infectious 
peritonitis (FIP), (B, E) dubiously consistent with FIP and (C, F) consistent with FIP, performed with (A–C) 
agarose gel electrophoresis and (D–F) capillary zone electrophoresis. A, D: no electrophoretic abnormality; 
B: α2-globulin but not γ-globulin increased; E: increased γ-globulin but not α2-globulin; C, F: both α2-and γ-
globulin are increased. 
 
Results  
Retrospective search and final caseload 
The following selection procedure, reported in figure 2, led to a final caseload of 91 AGE 
and 45 CZE. A similar proportion of effusive and non effusive forms was found in the two 
study period either for AGE or for CZE (dry forms = 3/17 [17.6%] in the first period; 5/24 
A 
B 
C 
D 
E 
F 
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[20.8%] in the second period) or for CZE (2/10 [20.0%] in the first period; 4/16 [25.0%] in 
the second period). 
 
 
Figure 2. Flow diagram summarising the selection of cases from the database. Samples from healthy cats 
were randomly excluded in order to level out the FIP and the NON FIP cats groups. 
*Absence of a final diagnosis; samples collected outside the study period (2004–09 or 2013–14); 
wrong/difficult separation of fractions. SDS-AGE= sodium dodecyl sulfate agarose gel electrophoresis. d= 
numbers of dry forms recorded in each period.  
 
 
Comparison between results obtained in the two study periods in healthy cats and in cats with FIP 
Results about the comparison of each electrophoretic fraction obtained in the two study periods 
are reported in table 1. Using AGE, no significant differences between the study periods were 
found in healthy cats. Conversely, in cats with FIP, the concentration of total protein and the 
concentration and the percentage of total- and γ-globulin were significantly lower, while the 
percentage of albumin, α2-globulins and the A/G ratio were significantly higher in recent years 
(2013-2014) compared with the former period (2004-2009). Using CZE, no significant differences 
were found between the two study periods, either in cats with FIP or in clinically healthy cats. The 
absence of statistically significant differences between healthy cats in the two study periods 
demonstrates that any possible difference found in FIP cats over time are unlikely imputable to 
changes in the analytical performance of the technique. 
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Table 1.   Comparison of each electrophoretic fraction between the two study periods in cats with FIP and 
healthy cats analysed with agarose gel (AGE) and capillary zone (CZE) electrophoresis. Results are 
presented as mean ± SD, median (in brackets) and I–III interquartile intervals  
*n = 14 for values in g/dl; †n = 22 for values in g/dl; ‡n = 9 for values in g/dl; 
§P <0.001 vs 2004–2009; ¶P <0.05 vs 2004–2009 ∞P <0.01 vs 2004–2009     
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Frequency of electrophoretic alterations in comparison with reference intervals  
In the first period (2004-2009) all the cats with FIP tested with AGE and most of the cats with FIP 
tested with CZE had hyperproteinemia (table 2), while the proportion of cats with FIP and 
hyperproteinemia was lower in the second period, with a significant difference for AGE.  
Independently on the electrophoretic technique, the proportion of FIP cats with a simultaneous 
increase of α2- and γ-globulin was similar in the two study periods, while in the second period a 
higher rate of cases characterized by an increase of α2-globulins without gammopathy and a lower 
rate of cases characterized by gammopathy but not by the increases of α2-globulin were found 
and, in this latter case, a significant difference was found for percentage values in samples 
processed by AGE, and for absolute values in samples processed with both the techniques. 
 
 
Table 2. Frequency of electrophoretic alterations compared with the reference intervals. 
Results are presented as number of observations/total number of cases (%) *P <0.05 vs 2004–2009  
 
Visual interpretation of electrophoretograms in the two time spans 
The agreement between the two operators resulted absolute (100%) for AGE. Using AGE, only half 
of the FIP cats showed the typical pattern of FIP, while this proportion increased using CZE, 
confirming that the sensitivity of this test is not absolute (table 3). Anyway, the diagnostic 
sensitivity of SPE resulted similar in the two examined time spans, while the number of the 
dubious patterns increased in the second period with AGE but not with CZE. However, all these 
differences were not statistically significant. 
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Table 3. Results of the visual interpretation analysis performed by two operators on the 
electrophoretograms of cats with feline infectious peritonitis (FIP).  
Results are presented as number of observations/total number of cases (%). 
 
Discussion 
In this study, the performance of SPE was retrospectively studied in order to understand if 
electrophoretic patterns not consistent with FIP, anecdotally observed in recent years in our 
laboratory in FIP cats, were really more frequent than in the past.  
In the FIP group, the percentage of effusive and non effusive forms was similar for the two 
electrophoretic techniques examined in this study and the proportion of samples retrospectively 
analysed after freezing and analysed with the two techniques was similar in the two periods, both 
demonstrating that changes in the electrophoresis patterns are unlikely associated with a different 
rate of effusive vs non effusive FIP and excluding that differences in the patterns could be 
associated with storage artefacts, which are anyway known to minimally affect SPE (Eckersall, 
2008; Stockham and Scott, 2008). Regarding FIP cats tested with AGE, total protein concentration 
was significantly lower in the recent period in comparison with the previous one. In addition, total 
protein concentrations in the recent period were frequently close to or lower than the reference 
intervals established in our laboratory. Both the relative and the absolute concentrations of total 
and γ-globulins were significantly lower in the second period. Therefore, the albumin/globulin 
ratio was significantly higher and frequently within the reference interval in FIP cats in the second 
period, in contrast with what reported by Sparkes et al. (1991), who recorded a high prevalence of 
low albumin/globulin ratio in FIP cats.  
The analysis of results obtained with CZE revealed the same trends over time either for total 
proteins and for electrophoretic fractions, but the differences were not statistically significant. 
Also, the comparison with the reference intervals in the two periods confirmed that the 
proportion of electrophoretic alterations in FIP cats for both the electrophoretic techniques was 
higher in the first period, also in this case with different statistical significance between AGE and 
CZE, likely due to the different numbers of samples in the caseload. While all the FIP cats analysed 
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with AGE and most of the cats analysed with CZE presented hyperproteinemia in the first period, 
this alteration was less frequent in the recent years. The most frequent difference between the 
two periods was the decreased frequency of hypergammaglobulinemia, which is known to be the 
most typical finding in FIP cats (Pedersen, 2009). Another interesting aspect was the increased 
percentage, in the second period and for both the techniques, of increased α2-globulins not 
associated with a concurrent gammopathy. Theoretically, the absence of the gammopathy may be 
imputable to the time of sampling since experimental studies showed that γ-globulins increase a 
couple of weeks later than the increased of α2-globulins (Addie et al., 2004). In the current study, 
in two cats with increased α2-globulin and normal γ-globulins tested in the first period of time (one 
with AGE and one with CZE), the gammopathy appeared when electrophoresis was repeated two 
weeks later. Conversely, three cats with the same electrophoretic profile tested in the second 
period (two with AGE and one with CZE) did not develop the gammopathy in samplings repeated 
in the following month. This suggests that in the second period of the study the high frequency of 
increased α2-globulin in the absence of gammopathy may not depend on the stage of the disease. 
The results of this study seem to indicate a less intense antigenic stimulation in FIP cats, reflected 
by γ-globulin concentrations lower than in the past and closer to the reference intervals of our 
laboratory. This finding is likely related to a lower concentration of immunoglobulins which are the 
most relevant proteins known to migrate in the gamma region (Stockham and Scott, 2008). A 
possible explanation for this finding is a variation of the host-coronavirus interactions, possibly 
due to changes in viral immunogenicity and/or to the development of a different immune 
response of the feline population analysed. The design of this study does not allow to investigate 
this pathogenic aspect, but our results are encouraging to design future studies on the 
characteristics of viral populations recently isolated or on host-virus interactions. Conversely, 
results on repeated samplings above mentioned tend to exclude the possibility that the 
differences reported over time depend on an earlier identification of symptoms as compatible 
with FIP by the referring veterinarians and consequently on the analysis of samples collected in an 
early stage of disease, when the antigenic response has not yet been triggered.  
Also, the possible effect of drug administration on the development of gammopathy seems 
unlikely since samples were submitted before the provisional diagnosis was emitted and therefore 
before starting any treatment.  
Even if the possible reasons for these changes were not investigated in this study, it is important 
to highlight how the absence of the typical electrophoretic alterations could affect the 
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interpretation of electrophoretograms and the diagnosis of FIP, especially in its non effusive form, 
since in this latter form tests on effusions (e. g. immunofluorescence, Rivalta’s test), which are 
known to be accurate, are not available (Hartmann, 2005; Fischer et al., 2012). Regarding this 
aspect, the visual interpretation performed on the electrophoretic patterns pointed out the low 
sensitivity of this approach for the diagnosis of FIP and also how the “dubious patterns” (e.g. the 
presence of one of the typical alterations for FIP alone) increased in the second period for AGE. 
The results obtained in this study with AGE were slightly discordant with those obtained with CZE, 
likely due to the higher resolution typical of this latter technique that allows to detect higher and 
narrower peaks, that may thus become visually evident also when percentage or absolute values 
are closer to or lower than the upper reference limits (Giordano and Paltrinieri, 2010). This 
information suggests that CZE, probably due to its analytical properties like its higher resolution 
compared with AGE (Giordano and Paltrinieri, 2010), may have a better sensitivity compared to 
AGE, especially in identifying the gammopathy, which seems to be less frequent in FIP cats in the 
recent time span.  
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IV. Comparison of the diagnostic performances of laboratory tests for the diagnosis of 
feline infectious peritonitis 
 
Material and methods 
Caseload and laboratory methods 
This was a retrospective study based on the results recorded with different clinico-pathological or 
molecular methods on samples submitted to the diagnostic laboratory of the DIMEVET laboratory 
between 2013 to 2015. The laboratory database was analysed to select data fulfilling the following 
criteria: 
- Clinical suspicion of FIP, based on history and clinical signs (fever, lethargy, anorexia, 
weight loss, neurological/ocular signs, effusions, etc.) 
- Availability of a final diagnosis, based on post-mortem findings or on 18 months follow 
up, as specified below 
- Presence of at least one result regarding the clinico-pathological tests (serum protein 
electrophoresis and α1-acid glycoprotein measurement on blood, cytology and ΔTNC 
measurement on effusions) or the molecular tests (nRT-PCR for 3’UTR and Spike gene 
sequencing on blood, effusions and tissues) included in this study. 
All the samples were analysed for routine diagnostic purposes and collected under informed 
consent of the owners, therefore a formal approval from the Ethical Committee was not required 
(EC decision 29 Oct 2012, renewed with the protocol n° 02-2016). 
Cats were assigned to the FIP group if typical histopathological findings along with a positive result 
on immunohistochemistry against the FCoV in at least one tissue were present (Figure 1) 
(Pedersen, 2009). Cats were assigned to the non-FIP group when histology revealed the presence 
of diseases other than FIP along with negative results on immunohistochemistry on all the 
sampled tissues, when the follow-up demonstrated a complete recovery (remission of the 
symptoms, normalization of the recorded laboratory alterations) after 18 months from the first 
diagnostic procedures, or when a definitive diagnosis was achieved through collateral laboratory 
and/or imaging analyses. 
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Figure 1. Example of a positive histology and immunohistochemistry for the assignation of the cats to the 
FIP group. A. Haematoxyilin-eosin stained section of a spleen showing a typical FIP lesion, with a necrotic 
center surrounded by neutrophils and macrophages. B. The same section with positive result at 
immunohistochemical examination, with the surrounding macrophages containing the viral antigen stained 
in golden/brown.  
 
Post-mortem examinations 
Cats euthanized by the referring veterinarians due to the worsening of the clinical conditions were 
kept refrigerated until subjected to necropsy within 6 hours. One specimen from all organs 
affected by gross lesions was collected, fixed in 10% buffered formalin and embedded in paraffin. 
Another specimen from at least one affected organ (mostly mesenteric lymph node) was 
immediately frozen at -80°C for molecular analyses.   
Histology was performed on microtomic sections (5 μm) stained with haematoxylin-eosin. 
Immunohistochemistry was performed using a mouse monoclonal antibody anti-FCoV (FIPV3-70 
clone, Serotec) and the standard avidin biotin complex (ABC- Vectastain Elite, Vector laboratories 
Inc.) method (Hsu et al., 1981). As a chromogen, 3,3’-Diaminobenzidine (DAB) (Vector 
Laboratories) was used. The slides were counterstained with Mayer’s haematoxylin. In each 
working session, a section of kidney from a cat with confirmed FIP served as positive control. 
Negative controls consisted of serial sections of tested tissues in which anti-FCoV antibody was 
replaced with normal not immune mouse serum (DAKO; Glostrup Denmark). 
On FIP cats, immunohistochemistry was performed on selected specimens with typical histological 
lesions, while in non-FIP cats all the tissues collected during necropsy were tested with 
immunohistochemistry, in order to definitively exclude the presence of FCoVs.  
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Tests on serum 
Total proteins were spectrophotometrically measured using the biuret method (Cobas Mira, 
Roche), then SPE was performed on agarose gel using the automated analyser Hydrasis (Sebia 
Italia Srl) and a specific kit (Hydragel 15 β1- β2, Sebia Italy Srl) as previously described (Giordano 
and Paltrinieri, 2010). Gels were scanned and data were analysed with the appropriate software 
(Phoresis, Sebia Italia Srl).  
The serum concentration of AGP was measured using a radial immunodiffusion kit (SRID, Tridelta 
Development Limited) as previously described (Paltrinieri et al., 2007).  
 
Tests on effusions 
Fresh effusions were analysed with the Sysmex XT-2000iV (Sysmex Europe GmbH, Norderstedt, 
Germany). The ΔTNC was recorded as reported in study I (see above).  
Cytological examination was performed by an ECVCP diplomate on smears or on cytocentrifuged 
samples stained with a rapid stain (Hemacolor, Merck).  
 
Molecular tests on blood, effusions and tissues 
Whole blood and effusions collected in EDTA were centrifuged (3,000 × g, 5 min) within 12 hours 
and the obtained pellets were suspended in 200 μL of PBS by vigorous vortexing and immediately 
stored at -20 °C for further RNA extraction.   
Samples were subjected to RNA extraction using a NucleoSpin RNA commercial kit (Macherey-
Nagel), according to the manufacturer’s instruction. The extracted RNA was screened for the 
presence of FCoV using a RT-nPCR targeting a 177 bp product of the highly conserved 3’ un-
translated region (3’ UTR) of the genome of both type I and type II FCoV (Herrewegh et al., 1995b). 
FCoV RNA was used as positive control and RNase-free water as negative control. PCR products 
were visualized under UV transilluminator on a 2% agarose gel stained with ethidium bromide. 
The extracted RNA subjected to S gene sequencing was previously tested using an RT-nPCR 
targeting a 142 bp product of the S gene (Chang et al., 2012). Positive samples were sequenced 
using the forward and reverse primers used for the second reaction. Sequencing was performed at 
an external laboratory (Parco Tecnologico Padano, Lodi, Italy) using a Big Dye Terminator version 
3.1 Cycle Sequencing kit and an AB3730 DNA Analyzer (Applied Biosystems).  
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Sequence data were assembled and manually corrected using BioEdit software version 7.01. 
Consensus sequences were aligned with FCoV strains bearing or not the mutations M1058L or 
S1060A, retrieved from GenBank, using Clustal X in the BioEdit software.  
 
Calculation of diagnostic performances 
Samples were classified as positive when features considered as consistent with FIP based on 
literature (table 1) were present, and as negative (not consistent with FIP) when findings reported 
in table 1 were absent or when features considered as dubious or suggestive (but not 
confirmatory) for FIP were present. Dubious features included the lack of granular background in 
cytological samples, ΔTNC values between 1.7 and 3.4 (the cut-off values established in study I), 
increased serum α2-globulins but normal γ-globulins or vice-versa, or AGP values between 0.56 
(reference value of the laboratory) and 1.5 mg/mL (figure 2) (Paltrinieri et al., 2007).  
When molecular tests were performed on more than one tissue specimen, cats were considered 
as positive when at least one of the tested organs provided a positive result and negative when all 
the tested organs resulted negative. 
For each test, TP and FP results (results consistent with FIP in cats with and without FIP, 
respectively), TN and FN results (results not consistent with FIP in cats without and with FIP, 
respectively) were recorded. Sensitivity, specificity, as well as positive and negative likelihood 
ratios (LR+ and LR-) were then calculated (Christenson, 2007).  
 
                                                          
1
 See http://www.mbio.ncsu.edu/BioEdit/bioedit.html 
Comparison of the diagnostic performances of laboratory tests for the diagnosis of feline 
infectious peritonitis 
62 
 
 
Figure 2.  Serum protein electrophoretic and cytological patterns used for the calculation of diagnostic 
performances. A: SPE consistent with FIP (increased α2- and γ globulin with a polyclonal peak; B: SPE not 
consistent with FIP (absence of α2- and γ globulin with a polyclonal peak); C: SPE dubious for FIP (presence 
of α2-globulin peak only); D: cytological pattern consistent with FIP (presence of an inflammatory non-
specific process and of a proteinaceous background);  E: cytological pattern not consistent with FIP 
(adenorcarcinoma), F: cytological pattern dubious for FIP (presence of an inflammatory non-specific 
process without the proteinaceous background). 
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Specimen Test Features and cut-offs consistent with FIP 
Effusion 
Cytology 
Presence of an inflammatory non-specific process and of a 
proteinaceous background 
ΔTNC  >3.4  
RT-nPCR 3’ UTR Positive result  
S gene sequencing Presence of M1058L or S1060A mutations 
Blood 
SPE Increased α2- and γ globulin with a polyclonal peak  
AGP >1.5 mg/mL  
RT-nPCR 3’ UTR Positive result  
S gene sequencing Presence of M1058L or S1060A mutations 
Tissues 
RT-nPCR 3’ UTR  Positive result  
S gene sequencing Presence of M1058L or S1060A mutations 
Table 1. Laboratory tests performed on the different specimens and features and/or cut-offs that were 
considered consistent with FIP (Herrewegh et al., 1995b; Sparkes et al., 1991; Paltrinieri et al., 2001; 
Paltrinieri et al., 2007; Pedersen, 2009; Chang et al, 2012).  
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Results 
Thirty cats (age range: four months to 13 years) suspected to have FIP because of their history and 
clinical signs were included in this study. The FIP group included 16 cats on which FIP was 
confirmed post-mortem through histology and positive immunohistochemistry on at least one 
examined tissue. 
The non-FIP group included 14 cats. In three of these, FIP was ruled out based on normalization of 
clinical and laboratory findings during a one-year follow-up (cats n° 20, 21 and 22, with persistent 
fever, inappetence and lethargy); in three cats a disease other than FIP was diagnosed through 
cytology, imaging and flow cytometry (cats n° 24 with hepatic carcinoma and cats n° 28 and 29, 
both with lymphoma); in 8 cats post-mortem findings were consistent with a disease other than 
FIP and no FCoVs were detected on tissues by immunohistochemistry (cats n° 17, 18, 19, 23, 25, 
26, 27 and 30 with renal failure, pleuro-pericardial fibrosis, pleomorphic sarcoma, lymphocytic 
cholangitis, intestinal carcinoma, myelofibrosis, polycystic kidney disease and lymphoma, 
respectively). 
The samples collected from each case are summarized in table 2, along with the results obtained 
in the different tests performed on blood, effusions or tissues. Sensitivity, specificity, and 
likelihood ratios of each test are reported in table 3. 
On blood, all the tests had a high or absolute specificity and a high LR+, while the sensitivity was 
low, except for the measurement of AGP. This test had the highest sensitivity and LR+ and the 
lowest LR-. SPE and S gene sequencing had the highest LR- values. 
On effusions, all the tests had high to absolute sensitivity and specificity and, consequently, high 
to absolute LR+ and low to excellent LR-, except for the S gene sequencing that had the worst 
performance in terms of sensitivity LR+ and LR-. 
On tissues, the RT-nPCR 3’UTR had the best sensitivity and a low LR-, but also low specificity and 
low LR+. Conversely, S gene sequencing had a high specificity and LR+ but a lower sensitivity and a 
slightly higher LR-. 
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Specimen Test Sens Spec LR+ LR- 
Blood 
SPE 42.9% 90.0% 4.29 0.63 
AGP 85.7% 81.8% 4.71 0.17 
3’ UTR PCR 75.0% 100.0% nc 0.25 
S gene sequencing 42.9% 100.0% nc 0.57 
Effusions 
Cytology 100.0% 83.3% 6.00 0.00 
ΔTNC 80.0% 100.0% nc 0.20 
3’ UTR PCR 100.0% 83.3% 6.00 0.00 
S gene sequencing 40.0% 83.3% 2.40 0.72 
Tissues 
3’ UTR PCR 90.9% 50.0% 1.82 0.18 
S gene sequencing 70.0% 87.5% 5.60 0.34 
Table 3. Sensitivity (Sens), Specificity (Spec), positive and negative likelihood ratio (LR+ and LR-, 
respectively) calculated for each test and specimens.  
ΔTNC: ratio between total nucleated cells counted on the two channels of the Sysmex XT-2000iV; SPE= 
serum protein electrophoresis; AGP= α1-acid glycoprotein; nc= not calculable based on the 100% specificity 
 
 
Discussion 
This study was designed to compare the diagnostic performances of some of the tests currently 
employed for the diagnosis of FIP since only few studies compared the diagnostic accuracy of 
different tests (Sparkes and others 1991, Paltrinieri and others 2001, Hartmann and others 2003, 
Giori and others 2011). Strict inclusion criteria (i.e. only cases with a conclusive diagnosis or with a 
complete recovery during the follow up were included in the study) were applied in order to 
increase the reliability of the results, but inevitably reducing the caseload. To minimize the 
negative effect of the small number of cases (and especially of “non-FIP cats”), the informative 
power of each test was calculated in terms of likelihood ratios that, contrarily to predictive values, 
are not influenced by the prevalence of the disease and may provide information about the tests 
that may increase or decrease the post-test probability of FIP (LR+ notably >1.0 or LR- close to 0.0, 
respectively). 
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Table 2. Specimens collected from each cat and results of the different tests performed on blood, effusions 
or tissue.* Presence of effusion; ΔTNC: ratio between total nucleated cells counted on the two channels of 
the Sysmex XT-2000iV; SPE= serum protein electrophoresis; AGP= α1-acid glycloprotein; - = not performed 
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In this study, in fact, the prevalence of FIP was higher than in similar previous reports that 
compared the diagnostic performances of different tests (Beatty and Barrs, 2010), since the 
number of cats with signs consistent with FIP but affected by other disease was low. Additionally, 
dubious results were considered as negative, since they cannot confirm the disease when taken 
alone. Moreover, the low rate of inflammatory conditions in the non-FIP group may have 
overestimated the specificity of tests suggestive of inflammation (cytology of the effusion, SPE, 
AGP measurement). Despite these limitations, this study confirmed that none of the tests 
examined in this study can be used alone to diagnose FIP. 
In blood, SPE had a very low sensitivity since FIP cats showed dubious or negative patterns, in 
disagreement with previous reports, and the LR ratios indicate that SPE cannot definitely rule out 
FIP but it may be a confirmatory test (Sparkes et al., 1991, Riemer et al., 2016). The sensitivity of 
AGP, although satisfactory and higher than that of all the other tests performed on blood, was 
lower than in previous reports (Giori et al., 2011). Nevertheless, the false negative cases had 
values consistent with inflammation (higher than the reference interval but lower than the cut-off 
consistent with FIP) which, in conjunction with other consistent laboratory results, may support 
the diagnosis of FIP. Interestingly, AGP showed also the lowest specificity and, although the LR- 
was not low enough to recommend the use of this test to rule out FIP, AGP was, along with the RT-
nPCR 3’UTR, the most reliable test on blood indicating that values higher than the cut-off may 
support a clinical diagnosis in presence of other changes consistent with FIP (Paltrinieri et al., 
2007). Based on the absolute specificity and on the relatively high LR-, also the molecular tests 
cannot be used to rule out FIP but they may support the diagnosis of FIP in the case of positive 
results. 
Cytology and the RT-nPCR 3’UTR were the best test on effusion, despite the presence of false 
positive results. This latter event, however, was rare (only one case in our caseload, characterized 
also by a false positive cytological result) and it may be explained by the fact that non-specific 
inflammatory cytological patterns are found in many inflammatory conditions (Paltrinieri et al., 
1999). Therefore, in accordance with previous reports, the cytology and the RT-nPCR 3’UTR cannot 
be used to confirm FIP (Giori et al., 2011, Kipar and Meli, 2014), but based on their high LR+ these 
are the tests of choice on effusion. The ΔTNC was specific but not as sensitive as expected, 
possibly due to the low cell concentration of the samples that provided false negative results also 
in study I. Hence, it may be used in addition to the other tests to support the diagnosis of FIP. The 
spike gene sequencing had a low sensitivity. Moreover, one false positive result was recorded, as 
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described by Porter and others (2014) who found the spike gene mutations described by Chang et 
al. (2012) in tissues of cats without FIP but in contrast with what reported by Longstaff et al. 
(2015), who found an absolute specificity of the spike gene sequencing on effusions. Therefore, 
the risk of false positive results, even if rare, make this test not optimal for the diagnosis of FIP.  
In tissues the sensitivity of RT-nPCR 3’UTR was high but not absolute, while the sensitivity of the 
spike gene was low. The negative results of the latter technique were due not only to the absence 
of the mutated nucleotides, but also to a negative result at the Spike PCR (data not shown) and to 
the resulting absence of sequencing templates.  The RT-nPCR 3’UTR showed a low specificity, 
confirming again what already described about the spread of the virus in cats not affected by FIP 
and the resulting false positive results (Kipar et al., 2006b). On the other hand, the specificity of 
the S gene sequencing was high as on the other specimens.  Thus, the risk of false positive results 
with the RT-nPCR 3’UTR is alarmingly high while the use of the S gene sequencing can be useful as 
a confirmatory test, but its use for the exclusion of FIP should be avoided based on the results of 
this study. A possible limitation of this study is that other mutations recently considered involved 
in the pathogenesis of FIP, such as the mutation of the 3c genes, have not been investigated. The 
inclusion of this additional molecular investigation would likely have provided more information 
on the pathogenesis of the disease and possibly on the inclusion of additional tests on the 
diagnostic workup. However, commercially available sequencing tests for FCoVs are currently 
mostly focused on the detection of mutations in the S genes and therefore, being this a 
comparative study among tests routinely introduced in diagnostic panels, we preferred to focus 
our attention on tests that are already in use and well known in routine diagnostic procedures. 
In conclusion, this study confirmed that the diagnosis of FIP may be challenging in practice since 
none of the clinico-pathological or molecular test, alone, may diagnose FIP. However, the present 
study provided useful practical information on the possible combination of tests that increases the 
post-test probability of disease based on different clinical scenarios. Specifically, any test on blood, 
and especially the molecular tests, may support or confirm a clinical diagnosis of FIP. However, 
except for AGP, a negative result does not exclude the presence of this disease. When effusions 
are present, cytology should be preferred because it is rapid, cheap and easy to perform and may 
work either as confirmatory test (especially when the pre-test probability of disease is not high) or 
as an exclusion test in the case of negative results. The 3’ UTR PCR has the same diagnostic 
performances than cytology but it is less practical to run. Conversely, the ∆TNC may confirm but 
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not exclude FIP and gene S sequencing on effusions cannot be recommended based on its lower 
performances in terms of LRs. On tissues, molecular tests may be run if immunohistochemistry is 
not available or if it provided dubious results. In this case, however, S gene sequencing should be 
preferred when histology is highly consistent with FIP while 3’ UTR PCR when FIP is less likely. 
It would be interesting, in the future, to investigate the diagnostic performances of combined 
tests, which unfortunately has not been done in this study due to the low number of cases on 
which all the tests included in the study were performed. 
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V. Reverse transcriptase loop-mediated isothermal amplification for the detection of 
feline coronavirus 
Material and methods 
Caseload and RNA extraction 
Thirty-two samples from 27 cats (11 feces, 9 blood, 8 effusions, and 4 mesenteric lymph nodes) 
submitted to the DIMEVET laboratory as part of a diagnostic panel for the clinical suspicion of FIP 
or, regarding feces, for screening purposes, were used.  RNA extraction was performed using a 
NucleoSpin RNA Isolation Kit (Macherey-Nagel Bethlehem, PA). Whole blood and effusion samples 
were centrifuged (3,500 x g, 5 min) and the obtained pellets were suspended in 200 μL of PBS by 
vigorous vortexing and stored at -20°C for further RNA extraction. Fecal samples were suspended 
at a final concentration of 10% (wt/vol) in PBS by vigorous vortexing. The supernatant was cleared 
by centrifugation (5,000 x g, 4 min) and stored at -20°C for further RNA extraction. For tissues, 
approximately 20 mg of sample were thinly shredded.  All the further RNA extraction steps were 
performed according to the manufacturer’s instruction. 
 
RT-nPCR 
The extracted RNA samples were tested for the presence of FCoV using a RT-nPCR targeting a 177 
bp product of the highly conserved 3’ UTR of the genome of both type I and type II FCoV 
(Herrewegh et al., 1995b). RT-nPCR positive FCoV RNA from a cat with FIP was used as positive 
control and RNase-free water as negative control. PCR products were visualized under UV 
transilluminator on a 2% agarose gel stained with ethidium bromide.  
 
LAMP primers design and reaction set-up 
The primers targeting the 3’UTR of the FCoVs were designed using the Primer Explorer V4 
software (http://primerexplorer.jp/elamp4.0.0/index.html) based on a 296 nucleotides sequence 
(28981 to 29277 bp) of the FCoV C1Je strain (accession number: DQ848678) (table 1). A Loopamp 
RNA amplification kit (RT-LAMP, New England Biolabs, UK) was used to perform RT-PCR LAMP and 
the reaction mixture was set up as follows: 1x Isothermal amplification buffer, 6 mM MgSO4, 1.4 
mM dNTPs, 320 U/mL of warm start DNA, 300 U/mL of warm start RTx Reverse Transcriptase, 2 
µM of both FIP and BIP primers, 0.2 µM of both F3 and B3 primers, 1 µM of both Loop F and Loop 
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B primers, 120 µM of Hydroxynaphtol blue (HNB) dye (Sigma-Aldrich®) and 5 µL of RNA template. 
The reaction mixture was then made up to 25 µL with RNase-free water and incubated in a 
thermal cycler (MyCycler, Bio-Rad Laboratories, Hercules, CA, USA) for 1 hour at 
63 °C followed by 10 minutes at 80 °C for heat inactivation. The same positive control used for 
traditional RT-nPCR, which tested positive also on the first RT-LAMP assay, was used as a positive 
control in the following RT-LAMP assays, , while RNase-free water was used as negative control.  
PRIMER GENOME TARGETING POSITION SEQUENCE (5’-3’) 
F3 28982-29002 GCAACCCGATGTTTAAAACTG 
B3 29179-29162  CCATTGTTGGCTCGTCAT 
FIP (F1c+F2) F1c, 29065-29043; F2, 29003-29023 
ACACGTGCTTACCATTCTGTACA-
GTCTTTCCGAGGAATTACTGG 
BIP (B1c+B2) B1c, 29077-29101; B2, 29161-29141 
CAAGCAACCCTATTGCATATTAGGA-
AGCGGATCTTTAAACTTCTCT 
LOOP F 29042-29024 AGAGTAGACAGCGCGATGA 
LOOP B 29103-29128 GTTTAGATTTGATTTGGCAATGCTAG 
Table 1. List of the primers (Primm Biotech, Italy) used in this study, based on the FCoV strain C1Je  
(GeneBank accession number: DQ848678). 
 
The products of the reaction were then inspected both by eye, in order to detect the color turning 
from violet to sky blue in case of positive results with HNB (Goto et al., 2009), and under UV 
transilluminator on a 2% agarose gel stained with ethidium bromide in order to detect a ladder-
like pattern in case of positive result (Parida et al., 2008) (Figure 1). Results obtained with RT-
LAMP were then compared with those obtained with the RT-nPCR and the sensitivity and 
specificity of RT-LAMP obtained with both HNB and agarose gel were calculated. 
 
Figure 1. Evaluation methods of RT-LAMP for feline coronavirus. A. Negative result (violet) with 
hydroxynaphtol blue. B. Positive result (light blue) with hydroxynapthol blue. C. Agarose gel 
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electrophoresis run showing 100 bp Ladder (lane 1); ladder like patterns typical of positive reaction 
(lanes 2 and 3); negative results (lanes 4 and 5). 
Results and discussion 
Results recorded in the different specimens are reported in table 1.  
 
ID Specimen PCR LAMP GEL LAMP HNB 
1 Feces POS POS POS 
2 Feces POS POS POS 
3 Feces POS POS POS 
4 Feces POS POS NEG 
5 Feces POS POS NEG 
6 Feces POS NEG POS 
7 Feces POS NEG NEG 
8 Feces POS NEG NEG 
9 Feces POS NEG NEG 
10 Feces POS NEG NEG 
11 Feces NEG NEG NEG 
Total positive results 10/11 5/11 4/11 
12 Blood POS POS POS 
13 Blood POS NEG POS 
14 Blood POS NEG NEG 
15 Blood POS NEG NEG 
16 Blood NEG NEG NEG 
17 Blood NEG NEG NEG 
18 Blood NEG NEG NEG 
19 Blood NEG NEG NEG 
20 Blood NEG NEG NEG 
Total positive results 4/9 1/9 2/9 
21 Effusion POS POS POS 
22 Effusion POS POS POS 
23 Effusion POS NEG POS 
24 Effusion POS NEG NEG 
25 Effusion POS NEG NEG 
26 Effusion NEG NEG NEG 
27 Effusion NEG NEG NEG 
28 Effusion NEG NEG NEG 
Total positive results 5/8 2/8 3/8 
29 Tissue POS POS POS 
30 Tissue POS POS POS 
31 Tissue POS POS POS 
32 Tissue NEG NEG NEG 
Total positive results 3/4 3/4 3/4 
 
Table 1. Results obtained on the samples tested with RT-nPCR (PCR) and LAMP and evaluated with agarose 
gel electrophoresis (LAMP GEL) and hydroxynaphtol blue dye (LAMP HNB).  
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All the negative samples using RT-nPCR were also negative by RT-LAMP, using both gel 
electrophoresis and HNB for the visualization of the results, leading to a 100% specificity.  
On the other hand, a conspicuous number of false negative results was recorded (11/22 for 
agarose gel and 10/22 for HNB) and the overall sensitivity was 50% and 54.5% using gel 
electrophoresis and HBN, respectively. The sensitivity of RT-LAMP was also different according to 
specimens: feces showed a sensitivity of 50% and 40%, with gel electrophoresis and HNB 
respectively. On blood, the sensitivity was 25% and 50%, with gel electrophoresis and HNB 
respectively while on effusions the sensitivity was 40% with both the visualization methods. Only 
on tissues, the sensitivity resulted to be absolute, but the number of tested samples was too low 
to be discussed in terms of diagnostic accuracy. Based on the results of this pilot study, RT-LAMP 
for FCoV, due to its high specificity,  appears to be a solid molecular test to confirm the diagnosis 
of FCoV infection, and eventually to support a clinical diagnosis of FIP, when performed on 
specimens from cats with an high pre-test probability of FIP (e.g. cats with clinical signs and 
laboratory findings consistent with FIP, like effusions with physico-chemical and cytological 
features consistent with FIP) but its low sensitivity makes this test not reliable in case of negative 
results (Pedersen, 2009). In the case the sensitivity of the test might be ameliorated through 
further studies, the RT-LAMP could be extremely useful, due to its low costs and rapidity, in those 
situations where the detection of FCoV must be repeated over time and on a high number of cats 
(e.g. breeding catteries). An additional future perspective would be the optimization of the test to 
obtain quantitative results, possibly by establishing a standard curve of color intensity using RNA 
samples with known viral load (e.g. quantification of RNA copies by quantitative PCR techniques). 
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VI. Feline coronavirus spike protein in cats with and without feline infectious 
peritonitis  
 
Material and methods 
A large biobank consisting of variable clinical specimens (tissues; body cavity fluid; feces) obtained 
from cats deceased for both FIP and other diseases (e.g. neoplasia, cardiac failure) and stored at  
-80°C at School of Veterinary Science (University of Bristol, UK) was used. For every cat from which 
samples were stored in the biobank, a full clinical evaluation along with histology and 
immunohistochemistry for the detection of feline coronavirus were available. 
 
Collection of samples 
Cats euthanized due to suspected FIP or to other diseases at the Small Animal Hospital (Langford 
Veterinary Services, University of Bristol) underwent necropsy and sample collection within two 
hours of death. In particular, at least five samples of 0.125 cm3 (maximum 5 mm in 
width/length/depth) from each of colon, small distal intestine, mesenteric lymph node, spleen, 
liver, kidneys, omentum and lungs were sectioned and immediately placed in RNA preservative 
RNAlater® (Life Technologies). Other kind of tissues (e.g. brain, eyes, pancreas) were also 
occasionally collected based on gross findings. A sample of feces and, if present, body cavitary 
effusions (abdominal, thoracic, pericardial, CSF) were also collected in plain tubes. Concurrently, 
tissue samples from the organs as reported above were collected into 10% neutral-buffered 
formalin for histopathology and immunohistochemistry tests. Samples collected in RNAlater were 
refrigerated for 24-48 hours, prior to storage at -80°C. Fecal samples were immediately stored at -
80°C.  
 
RNA extraction and qPCR 
Regarding tissues, RNA was purified from 20 mg tissue using a NucleoSpin RNA II Kit (Macherey-
Nagel) according to manufacturer’s instructions, following disruption using a Qiagen Retsch 
MM300 TissueLyser (Qiagen, Hilden, Germany). Regarding feces, RNA was purified from 10 mg 
feces (100 µl of 500 mg of feces suspended in 4,5 mL of phosphate buffered saline (PBS), or fecal 
swabs (resuspended in 100 µL PBS), using the Chemagic 360 instrument (Perkin-Elmer) in 
combination with Chemagic body fluids NA kit (Perkin-Elmer). Regarding fluids, RNA was purified 
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from 100 µl fluid using the Chemagic 360 instrument in combination with Chemagic body fluids NA 
kit. The resulting RNA was stored at -80°C until further analysis. 
All samples underwent reverse transcription (RT) on a MJ Mini Gradient Thermal Cycler using the 
ImProm II Reverse Transcriptase (Promega) kit. The reaction mixture comprised 4 µL of 5X ImProm 
II buffer, 1 µL of random hexamers (0.5 µg/ µL), 2.4 µL of 25 mM MgCl2, 1 µL of dNTPs (10 mM 
each), 1 µL of ImProm RT enzyme, 10 µL of RNA template and was made up to 20 μL with RNase-
free water. Thermal conditions were: 20 °C for 5 minutes, 42 °C for 30 minutes, 70 °C for 15 
minutes and 10 °C hold. The obtained complementary DNA was added to 30 µL of RNase-free 
water and stored at -20 °C for further analyses or immediately used. For fecal RT samples, an RNA 
internal amplification control was used to check the presence of RT inhibitors.  
A quantitative PCR (qPCR) for the detection of FCoVs was performed on all the cDNA samples. An 
Agilent Mx3005P qPCR System (Agilent Technologies) thermocycler was used. The reaction 
mixture was prepared as follows: 12.5 µL of 2x GoTaq polymerase, 0.5 µL each of 10 μM forward 
(P009:AGCAACTACTGCCACRGGAT, position 26655-26674 of the FCoV strain 79-11461) and reverse 
(P010:GGAAGGTTCATCTCCCCAGT, position 26826-26807 of the FCoV strain 79-11461) primers, 
0.125 µL of 5 µM FAM TaqMan probe, 1.25 µL of 50 nM MgCl2, 5 µL of cDNA template, and made 
up to 25 μL with RNase-free water. The primers, targeting a conserved 171 bp region between the 
M and the N gene, were previously described by Dye et al. (2008).  The following thermal profile 
was used: 95 °C for 2 minutes, followed by 40 cycles of 95 °C for 15 seconds, 55 °C for 15 seconds 
and 72 °C for 15 seconds. Feline coronavirus cDNA was used as a positive control and RNase-free 
water as a negative control. Reactions that did not reach the threshold cycle (Ct) value after 40 
cycles were categorized as negative and a relative copy number of 1 was assigned to a Ct value of 
40.  
 
Pyrosequencing 
All samples that were positive by FCoV qRT-PCR underwent conventional PCR to amplify a 153 bp 
DNA fragment, which including the sequences encoding for positions 1058 and 1060 of the spike 
protein. The PCR was performed on a MJ Mini Gradient Thermal Cycle with a reaction mixture 
containing: 12.5 µL of 2x GoTaq polymerase, 1 µL each of 10 µM forward (F614: 
GCHCARTATTAYAATGGCATAATGG, position 23436-23460 of the FCoV C1Je2 strain) and 
biotinylated reverse (R766: BIO-AAGYCTRGCYTGYACTTGCAT, position 23588-23568 of the FCoV 
C1Je2 strain) primers, 2 µL of the template cDNA, and made up to 25 µL with RNase-free water. 
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The following thermal profile was used: 95 °C for 2 minutes, followed by 40 cycles at 95 °C for 15 
seconds, 52 °C for 20 seconds and 72 °C for 20 seconds. The amplification products were stored at 
-20 °C for further analyses or immediately pyrosequencing. Samples that did not pyrosequence 
were amplified for 50 cycles. 
The pyrosequencing used in this study is aimed to detect the two mutations described by Chang et 
al (2012).  At first, the PCR biotinylated products underwent the chemical separation in single 
strands through the binding with streptavidin Sepharose beads (Fisher). For each sample, the 
binding reaction mixture was prepared as follows: 40 µL of PyroMark binding buffer (Qiagen), 1 µL 
of streptavidin Sepharose beads and 25 µL of PCR product, made up to 80 µL total with RNase free 
water. The mixture was placed on a shaking block for 10 min at 1400 rpm. To prepare the 
sequencing plate, the following reaction mixture was prepared for each sample: 38 µL of 
PyroMark annealing buffer (Qiagen) and 2 µL of 10 µM sequencing primer (S680: 
ACAGCCTCDTTAATAGGVGGATG, position 23502-23524 of the FCoV C1Je2 strain). Forty µL of the 
sequencing mix were added to the apposite wells of the sequencing plates and the plate was 
placed on the pyrosequencing workstation of the PyroMark Q96 (Qiagen). 
The trays of the pyrosequencing workstation were filled with washing solution buffer (10 mM Tris-
OAc pH 7.6), denaturing solution (0.2 M NaOH), 70% ethanol and distilled water. The streptavidin 
beads already bound with the S gene qPCR biotinylated products were then gently aspirated by 
the pyrosequencing bead collector connected to a vacuum, after a cleaning step of the bead 
collector with distilled H2O. The bead collector was then placed in the 70% ethanol for 5 seconds, 
in the denaturing solution for 5 seconds and in the wash solution for 10 seconds. The vacuum was 
then turned off and the bead collector was placed in the pyrosequencing plate and gently agitated 
for 40 seconds to let the beads to detach. To let the primers to anneal to the the beads, the plate 
was heated at 80 °C for 2 minutes on a plate holder, and then left to cool for 5 minutes in the 
PyroMark Q96. In the meanwhile, the pyrosequencing cartridge was set with the following 
reagents in the wells and with the volumes indicated by the PyroMark Q96 software: PyroMark 
Gold Q96 enzyme, substrate and dNTPs (Qiagen). The dispensation order of the dNtPs was: 
CGCTCATG. The cartridge was then placed into the PyroMark Q96 and the assay was run.  
After the first experiments, the pyrosequencing of the target sequence was doubled, in order to 
look for the two possible mutations in two separated work sessions. This decision was taken after 
the failing of some pyrosequencing, possibly due to the formation of loops in the chosen primer or 
to the variability of the sequence. The second pyrosequencing (aimed to detect the mutation 
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S1060A) was performed on each sample after the first above described and with the same 
protocol, except for the use of a different sequencing primer (S693 instead of S680) and 
dispensation order of the dNTPs.  
 
Results analysis 
Cats were classified as FIP, non-FIP, or inconclusive based on histology and immunohistochemistry 
results. Cats were assigned to the FIP group if histology revealed the presence of the typical 
histological lesions (e.g. pyogranulomas-granulomas, vasculitis, fibrinoid necrosis) and if the FCoV 
antigen was found within the lesion macrophages.  
All the pyrograms have been downloaded from the PyroMark Q96 software and are currently 
under evaluation. Each pyrogram will be analyzed in order to assign the corresponding codon to 
the peaks. To every sample obtained from each cat, the Ct values and the presence/absence of 
one or both the mutations described by Chang et al (2012) will be assigned. 
Therefore, results of this part of study VI are too preliminary to provide useful information on the 
pathogenesis of FIP/FCoV infection and are not included in the current version of the thesis. 
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VI.1. Feline coronavirus shedding in cats with and without feline infectious peritonitis. 
 
Briefly, 83 samples of feces and seven fecal swabs were collected from 90 cats for which 
histopathology results were also available. Cats were classified as FIP, non-FIP, or inconclusive 
based on histology and immunohistochemistry results. Cats were assigned to the FIP group if 
histology revealed the presence of the typical histological lesions (e.g. pyogranulomas-
granulomas, vasculitis, fibrinoid necrosis) and if the FCoV antigen was found within the lesion 
macrophages. Inconclusive cats (histology consistent with FIP but with negative results at 
immunohistochemistry for FCoV) were not included in the study). 
 
Results and discussion 
Forty-eight cats were classified as FIP and 42 as non-FIP.  
Thirtyone (31/48) samples from the FIP group were FCoV RT-qPCR positive as well as 12 cats 
(12/42) from the non-FIP group. Pyrograms were unreadable for five FIP cats and for two non-FIP 
cats. The failure in the pyrosequencing could be attributed to a failure of the sequencing primers 
more than to a failure of the PCR targeting the S gene, this latter finding being confirmed with the 
specific band appearance when the PCR products were run on the agarose gel. Another 
explanation could be the formation of loop/helix structures in the sequencing primers, as 
predicted using M-Fold web server which also recorded melting temperature higher than those 
used in the pyrosequencing. The low copy numbers produced with the RT-qPCR could be another 
explanation as well the presence of type II FCoVs in the feces. The spike gene protein of this 
serotype, in fact, has sequences more similar to that of the CCoV and could prevent the binding of 
the primers. 
The remaining pyrograms were from 26 cats with FIP and from 10 without FIP. Thirteen FIP cats 
(13/26) were shedding the FCoV with the M1058L mutation described by Chang et al. (2012) as 
well as two (2/10) of the non-FIP cats.  
The results obtained are in contrast with those reported in previous papers, where the fecal 
samples obtained from non FIP cats did not show the M1058L mutation (Chang et al., 2012; Porter 
et al., 2014). On the other hand, this study demonstrates that FIP cats are more likely to shed FCoV 
with feces, at least twice as non-FIP cats. Moreover, it is possible that the spread of mutated 
FCoVs may play a role in the pathogenesis of FIP, differently from what reported in previous 
studies (Pedersen, 2009). This latter finding could have not been investigated in this study, but it 
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would be interesting to determine the presence of 3c mutations in the same fecal samples, since 
its truncations seems to increase the viral pathogenicity (Hora et al., 2016). Another approach 
could be to evaluate the infectivity of these strains for enterocyte cell lines, as tried in recent 
studies (Desmarets et al., 2013). 
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This thesis was aimed to find new approaches for the diagnosis of FIP and FCoV infection, since 
one of the main problematic aspects of this disease is the absence of a gold standard for the 
diagnosis in vivo. A new LAMP test was developed and, although further studies are needed to 
completely investigate the diagnostic potential of this test, its use in clinical practice could help to 
add more information during the diagnostic as well as  the screening procedure, due to its 
advantageous properties. Within this thesis The diagnostic potential of the ΔTNC has been fully 
exploited through two sequential studies and this test may become extensively available in routine 
practice, either on fresh or on frozen effusions. On the other hand, one of the classic test to 
perform on serum (i.e. SPE) was found to be less reliable for the diagnosis of FIP, showing the 
need for the development of additional tests and for deepening the reason of this change. The 
most useful tests to perform in vivo were determined, including a molecular test recently 
proposed to discriminate the two FCoV pathotypes. This latter test was also investigated in a wide 
number of samples during the externship at the University of Bristol and, although most of the 
results collected during the externship are very preliminary and ultimately did not allow us to 
provide additional information on the pathogenesis of FIP, these results may be of interest to 
further investigate the genomic variability through the completion of the analysis so far 
performed, or through similar future studies on this topic. Nonetheless, the molecular study run 
during the externship showed for the first time the presence of the mutated virus also in feces of 
non FIP cat. This result ultimately open some interesting questions on the pathogenesis of the 
disease and on the need of novel testing strategies to control the spread of infection in multicat 
households.  
Specifically, the main conclusions of this thesis are: 
 
 The ΔTNC measurement on feline effusions has a high diagnostic accuracy for the diagnosis 
of FIP. Two cut-offs were determined. A ΔTNC >1.7 FIP is suggestive of FIP, while a ΔTNC 
>3.4 can be considered diagnostic for FIP. 
 The ΔTNC measurement can be performed also on effusion supernatants (e.g. on frozen, 
stored sample) after the addition of feline blood samples in 1:10 dilution.  
 Serum protein electrophoresis performed in FIP cats in recent years showed a decrease in 
hyperproteinemia and hypergammaglobulinemia, compared with both previous years and 
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with reference intervals. This finding suggests possible changes in the virus-host 
interaction. 
 The comparison between different tests for the diagnosis of FIP identified AGP on blood 
and cytology and RT-nPCR on effusions as the best tests to perform in vivo. On tissues, RT-
PCR and spike gene sequencing may be useful to exclude and confirm the disease, 
respectively. 
 With the settings used in this study, RT-LAMP showed absolute specificity but poor 
sensitivity in all the samples except on the few number of tissues evaluated. Thus, it could 
be used as a confirmatory test but not to exclude FCoV infections. 
 FIP cats are more prone to shed FCoV in feces. Moreover, the M1058L was found in feces 
of cats died for FIP but also for diseases other than FIP. The shedding of mutated FCoV may 
have a role in the pathogenesis of FIP. 
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